| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RIN3 GBF1 OBSCN ARHGEF17 FGD5 HERC1 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 RASGEF1C SMCR8 PSD4 | 1.81e-07 | 231 | 280 | 16 | GO:0005085 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RIN3 GBF1 MYO9B OBSCN ARHGEF17 BNIP2 FGD5 HERC1 PREX1 ARHGAP21 RASAL1 GARNL3 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 RASGEF1C SMCR8 ARHGAP45 PSD4 | 3.10e-06 | 507 | 280 | 22 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RIN3 GBF1 MYO9B OBSCN ARHGEF17 BNIP2 FGD5 HERC1 PREX1 ARHGAP21 RASAL1 GARNL3 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 RASGEF1C SMCR8 ARHGAP45 PSD4 | 3.10e-06 | 507 | 280 | 22 | GO:0030695 |
| GeneOntologyMolecularFunction | histone modifying activity | NCOA3 KMT2B SRCAP GTF3C4 TTLL12 EHMT2 MIER2 CREBBP ASH2L SETD5 TRIM37 KDM1A | 9.98e-05 | 229 | 280 | 12 | GO:0140993 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.58e-04 | 37 | 280 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAP1A MAP1B MYO9B SPTB OBSCN FXYD5 CCDC88B TTLL12 ABRAXAS2 PTPN4 BLOC1S6 PTPRC ARC DMD MYO18B MAP4K4 SGIP1 ANK2 KIF26B KLC2 TRIOBP PTPRT TIAM1 ARHGEF10 MAST1 FMN2 SNTA1 EPB41L1 FRMD3 MYBPC2 NIN | 1.73e-04 | 1099 | 280 | 31 | GO:0008092 |
| GeneOntologyMolecularFunction | D4 dopamine receptor binding | 1.96e-04 | 2 | 280 | 2 | GO:0031751 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.86e-04 | 125 | 280 | 8 | GO:0015108 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | CHD1 TTLL12 ABRAXAS2 PWWP2A ASCC2 ANK2 POU5F1B CBX4 PARP10 SETD5 | 6.84e-04 | 206 | 280 | 10 | GO:0140030 |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 7.03e-04 | 13 | 280 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 7.03e-04 | 13 | 280 | 3 | GO:0140829 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | LZTR1 GBF1 PDGFRB MYO9B OBSCN ARHGEF17 BNIP2 FGD5 MAP4K4 PREX1 ARHGAP21 RASAL1 GARNL3 RASGRF2 KALRN ARHGEF18 ARHGEF15 CSF1 TIAM1 ARHGEF10 ARHGAP45 AGRN PSD4 | 1.28e-10 | 333 | 274 | 23 | GO:0051056 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | LZTR1 GBF1 PDGFRB MYO9B OBSCN ARHGEF17 BNIP2 FGD5 MAP4K4 PREX1 ARHGAP21 RASAL1 GARNL3 RASGRF2 KALRN ARHGEF18 ARHGEF15 CSF1 TIAM1 ARHGEF10 RASGEF1C ARHGAP45 AGRN PSD4 | 2.53e-07 | 538 | 274 | 24 | GO:0007264 |
| GeneOntologyBiologicalProcess | cell morphogenesis | NES MAP1A MAP1B MYO9B DACT2 PTEN RNF157 HECW2 ARL13B ARC FGD5 STRC DMD MAP4K4 RASAL1 STRCP1 CUX2 KALRN NTRK3 TRIOBP ARHGEF18 ENAM LIFR COL18A1 TIAM1 ZNF335 RERE SCRIB AGRN DCLK1 TOP2B CUX1 KDM1A NIN | 2.32e-05 | 1194 | 274 | 34 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of enamel mineralization | 4.50e-05 | 6 | 274 | 3 | GO:0070175 | |
| GeneOntologyBiologicalProcess | neuron development | ERCC6 MAP1A MAP1B PCDH12 PTEN RNF157 BLOC1S6 BHLHA15 HECW2 ARC STRC DMD HERC1 MAP4K4 PREX1 RASAL1 STRCP1 CUX2 KALRN NTRK3 ROR2 TRIOBP CREBBP LIFR TIAM1 TMEM132E ZNF335 RP1L1 MFSD8 RERE SCRIB AGRN TNXB DCLK1 TOP2B CUX1 KDM1A NIN | 5.54e-05 | 1463 | 274 | 38 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | MAP1B LRFN3 PTEN CLN3 ARC ADGRL2 CUX2 KALRN NTRK3 ROR2 PTPRT ARHGEF15 TIAM1 SETD5 AGRN DCLK1 | 6.61e-05 | 387 | 274 | 16 | GO:0050807 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 NCOA3 ERCC6 KMT2B BCL7C CHD1 RNF40 CHD3 POGZ SRCAP GTF3C4 PWWP2A TFPT BRD8 EHMT2 TAF11 MIER2 SAMD1 CBX4 CREBBP ASH2L PARP10 SETD5 ZNF335 SMARCA1 RERE MRGBP TRIM37 KDM1A | 6.89e-05 | 999 | 274 | 29 | GO:0071824 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | MAP1B LRFN3 PTEN CLN3 ARC ADGRL2 CUX2 KALRN NTRK3 ROR2 PTPRT ARHGEF15 TIAM1 SETD5 AGRN DCLK1 | 8.39e-05 | 395 | 274 | 16 | GO:0050803 |
| GeneOntologyBiologicalProcess | neuron projection development | ERCC6 MAP1A MAP1B PTEN RNF157 BLOC1S6 BHLHA15 HECW2 ARC STRC DMD HERC1 MAP4K4 PREX1 RASAL1 STRCP1 CUX2 KALRN NTRK3 ROR2 TRIOBP CREBBP LIFR TIAM1 ZNF335 RERE SCRIB AGRN TNXB DCLK1 TOP2B CUX1 KDM1A NIN | 9.93e-05 | 1285 | 274 | 34 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | MYO9B MAP4K4 PREX1 KALRN NTRK3 ARHGEF15 TIAM1 ARHGEF10 SCRIB SMCR8 ARHGAP45 AGRN | 1.10e-04 | 244 | 274 | 12 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 1.50e-04 | 146 | 274 | 9 | GO:2000779 | |
| GeneOntologyBiologicalProcess | chromatin organization | NCOA3 ERCC6 KMT2B BCL7C CHD1 RNF40 CHD3 SRCAP GTF3C4 PWWP2A TFPT BRD8 EHMT2 MIER2 SAMD1 CBX4 CREBBP ASH2L PARP10 SETD5 ZNF335 SMARCA1 RERE MRGBP TRIM37 KDM1A | 1.67e-04 | 896 | 274 | 26 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | MYO9B FGD5 MAP4K4 PREX1 RASAL1 KALRN NTRK3 ARHGEF15 TIAM1 ARHGEF10 SCRIB SMCR8 ARHGAP45 AGRN | 1.68e-04 | 335 | 274 | 14 | GO:0043087 |
| GeneOntologyBiologicalProcess | memory | MAP1A PTEN ABCA7 BLOC1S6 EHMT2 PPP1R1B ARC CUX2 KALRN CREBBP | 1.75e-04 | 183 | 274 | 10 | GO:0007613 |
| GeneOntologyBiologicalProcess | protein localization to M-band | 1.76e-04 | 2 | 274 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | centrosome-templated microtubule nucleation | 1.76e-04 | 2 | 274 | 2 | GO:0090222 | |
| GeneOntologyBiologicalProcess | positive regulation of tooth mineralization | 1.84e-04 | 9 | 274 | 3 | GO:0070172 | |
| GeneOntologyCellularComponent | chromatin | NCOA3 ERCC6 AKAP8 BCL7C CHD1 IRF7 RNF40 CHD3 POGZ SRCAP ZBTB37 TFPT BRD8 EHMT2 BHLHA15 ZBTB5 HSF1 POU2F3 FOXI1 FOXN1 CUX2 MAGED1 REL POLE4 ICE1 POU5F1B CREBBP ASH2L PELP1 SETD5 SMARCA1 GMEB1 MTBP ZFHX3 TNKS1BP1 MRGBP SMCR8 TOP2B CUX1 KDM1A | 1.12e-05 | 1480 | 275 | 40 | GO:0000785 |
| Domain | RhoGEF | OBSCN ARHGEF17 FGD5 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 5.03e-08 | 68 | 272 | 10 | SM00325 |
| Domain | RhoGEF | OBSCN ARHGEF17 FGD5 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 6.69e-08 | 70 | 272 | 10 | PF00621 |
| Domain | DH_2 | OBSCN ARHGEF17 FGD5 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 6.69e-08 | 70 | 272 | 10 | PS50010 |
| Domain | - | OBSCN ARHGEF17 FGD5 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 7.69e-08 | 71 | 272 | 10 | 1.20.900.10 |
| Domain | DH-domain | OBSCN ARHGEF17 FGD5 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 7.69e-08 | 71 | 272 | 10 | IPR000219 |
| Domain | DH_1 | OBSCN ARHGEF17 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 3.07e-07 | 63 | 272 | 9 | PS00741 |
| Domain | PH_dom-like | OBSCN FRS3 ARHGEF17 PTPN4 PHLDB1 FGD5 PREX1 ARHGAP21 RASAL1 RASGRF2 KALRN TRIOBP ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 PLCH2 SNTA1 EPB41L1 FRMD3 PSD4 | 1.25e-06 | 426 | 272 | 21 | IPR011993 |
| Domain | PH | OBSCN PHLDB1 FGD5 PREX1 ARHGAP21 RASAL1 RASGRF2 KALRN TRIOBP ARHGEF18 TIAM1 PLCH2 SNTA1 PSD4 | 7.09e-06 | 229 | 272 | 14 | PF00169 |
| Domain | - | OBSCN FRS3 ARHGEF17 PTPN4 PHLDB1 FGD5 PREX1 ARHGAP21 RASAL1 RASGRF2 KALRN TRIOBP ARHGEF18 TIAM1 PLCH2 EPB41L1 FRMD3 PSD4 | 1.85e-05 | 391 | 272 | 18 | 2.30.29.30 |
| Domain | PH | OBSCN PHLDB1 FGD5 PREX1 ARHGAP21 RASAL1 RASGRF2 KALRN TRIOBP ARHGEF18 TIAM1 PLCH2 SNTA1 PSD4 | 6.11e-05 | 278 | 272 | 14 | SM00233 |
| Domain | PDZ | PTPN4 TJP2 PREX1 ARHGAP21 LNX2 TIAM1 MAST1 SCRIB SNTA1 AHNAK2 | 6.35e-05 | 148 | 272 | 10 | SM00228 |
| Domain | PH_DOMAIN | OBSCN PHLDB1 FGD5 PREX1 ARHGAP21 RASAL1 RASGRF2 KALRN TRIOBP ARHGEF18 TIAM1 PLCH2 SNTA1 PSD4 | 6.35e-05 | 279 | 272 | 14 | PS50003 |
| Domain | PH_domain | OBSCN PHLDB1 FGD5 PREX1 ARHGAP21 RASAL1 RASGRF2 KALRN TRIOBP ARHGEF18 TIAM1 PLCH2 SNTA1 PSD4 | 6.60e-05 | 280 | 272 | 14 | IPR001849 |
| Domain | - | PTPN4 TJP2 PREX1 ARHGAP21 LNX2 TIAM1 MAST1 SCRIB SNTA1 AHNAK2 | 7.11e-05 | 150 | 272 | 10 | 2.30.42.10 |
| Domain | PDZ | PTPN4 TJP2 PREX1 ARHGAP21 LNX2 TIAM1 MAST1 SCRIB SNTA1 AHNAK2 | 7.52e-05 | 151 | 272 | 10 | PS50106 |
| Domain | PDZ | PTPN4 TJP2 PREX1 ARHGAP21 LNX2 TIAM1 MAST1 SCRIB SNTA1 AHNAK2 | 7.95e-05 | 152 | 272 | 10 | IPR001478 |
| Domain | SNF2_N | 9.21e-05 | 32 | 272 | 5 | PF00176 | |
| Domain | SNF2_N | 9.21e-05 | 32 | 272 | 5 | IPR000330 | |
| Domain | fn3 | 1.35e-04 | 162 | 272 | 10 | PF00041 | |
| Domain | Helicase_C | 1.71e-04 | 107 | 272 | 8 | PF00271 | |
| Domain | HELICc | 1.71e-04 | 107 | 272 | 8 | SM00490 | |
| Domain | Helicase_C | 1.83e-04 | 108 | 272 | 8 | IPR001650 | |
| Domain | DEXDc | 1.95e-04 | 109 | 272 | 8 | SM00487 | |
| Domain | HELICASE_CTER | 1.95e-04 | 109 | 272 | 8 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.95e-04 | 109 | 272 | 8 | PS51192 | |
| Domain | Helicase_ATP-bd | 2.08e-04 | 110 | 272 | 8 | IPR014001 | |
| Domain | TMEM183 | 2.11e-04 | 2 | 272 | 2 | IPR026509 | |
| Domain | PDZ | 2.27e-04 | 141 | 272 | 9 | PF00595 | |
| Domain | - | 2.40e-04 | 9 | 272 | 3 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 2.40e-04 | 9 | 272 | 3 | IPR013769 | |
| Domain | Band_3_cyto | 2.40e-04 | 9 | 272 | 3 | PF07565 | |
| Domain | GDS_CDC24_CS | 2.42e-04 | 39 | 272 | 5 | IPR001331 | |
| Domain | PTrfase/Anion_transptr | 3.40e-04 | 10 | 272 | 3 | IPR016152 | |
| Domain | HCO3_transpt_C | 3.40e-04 | 10 | 272 | 3 | IPR011531 | |
| Domain | HCO3_transpt_euk | 3.40e-04 | 10 | 272 | 3 | IPR003020 | |
| Domain | HCO3_cotransp | 3.40e-04 | 10 | 272 | 3 | PF00955 | |
| Domain | FN3 | 3.94e-04 | 185 | 272 | 10 | SM00060 | |
| Domain | - | 5.93e-04 | 27 | 272 | 4 | 1.10.260.40 | |
| Domain | Anion_exchange_CS | 6.28e-04 | 3 | 272 | 2 | IPR018241 | |
| Domain | MAP1 | 6.28e-04 | 3 | 272 | 2 | IPR026074 | |
| Domain | FN3 | 6.97e-04 | 199 | 272 | 10 | PS50853 | |
| Domain | FA | 7.84e-04 | 13 | 272 | 3 | PF08736 | |
| Domain | FERM-adjacent | 7.84e-04 | 13 | 272 | 3 | IPR014847 | |
| Domain | FA | 7.84e-04 | 13 | 272 | 3 | SM01195 | |
| Domain | Lambda_DNA-bd_dom | 7.84e-04 | 29 | 272 | 4 | IPR010982 | |
| Domain | FN3_dom | 1.01e-03 | 209 | 272 | 10 | IPR003961 | |
| Domain | Bcl2-/adenovirus-E1B | 1.24e-03 | 4 | 272 | 2 | IPR022181 | |
| Domain | BNIP2 | 1.24e-03 | 4 | 272 | 2 | PF12496 | |
| Domain | SCAN | 1.32e-03 | 56 | 272 | 5 | SM00431 | |
| Domain | - | 1.39e-03 | 218 | 272 | 10 | 1.10.10.10 | |
| Domain | SCAN | 1.54e-03 | 58 | 272 | 5 | PF02023 | |
| Domain | SCAN_BOX | 1.54e-03 | 58 | 272 | 5 | PS50804 | |
| Domain | SCAN_dom | 1.54e-03 | 58 | 272 | 5 | IPR003309 | |
| Domain | Retrov_capsid_C | 1.66e-03 | 59 | 272 | 5 | IPR008916 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | OBSCN ARHGEF17 PREX1 MAGED1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 9.96e-09 | 59 | 202 | 10 | M11215 |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | OBSCN ARHGEF17 PREX1 MAGED1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 1.23e-07 | 76 | 202 | 10 | M19832 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | MYO9B OBSCN ARHGEF17 TJP2 PREX1 ARHGAP21 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 ARHGAP45 | 2.21e-07 | 149 | 202 | 13 | M41805 |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | OBSCN ARHGEF17 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 ARHGEF10 | 6.78e-07 | 52 | 202 | 8 | MM14743 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | MYO9B OBSCN ARHGEF17 TJP2 PREX1 ARHGAP21 RASGRF2 KALRN ARHGEF18 ARHGEF15 ARHGEF10 ARHGAP45 | 9.22e-07 | 142 | 202 | 12 | MM15576 |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | OBSCN ARHGEF17 PREX1 MAGED1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 1.24e-06 | 97 | 202 | 10 | M9400 |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | OBSCN ARHGEF17 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 2.05e-06 | 80 | 202 | 9 | M800 |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | OBSCN ARHGEF17 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 ARHGEF10 | 6.82e-06 | 70 | 202 | 8 | MM14824 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | MYO9B NHS FGD5 PREX1 ARHGAP21 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 ARHGAP45 | 1.37e-05 | 184 | 202 | 12 | M41809 |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | OBSCN ARHGEF17 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 ARHGEF10 | 1.40e-05 | 77 | 202 | 8 | MM15044 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | MYO9B OBSCN FRS3 ARHGEF17 ARL13B TJP2 NHS FGD5 PREX1 ARHGAP21 RASGRF2 KALRN ARHGEF18 ARHGEF15 AKAP12 TIAM1 ARHGEF10 SCRIB ARHGAP45 | 2.58e-05 | 450 | 202 | 19 | M27078 |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | OBSCN ARHGEF17 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 ARHGEF10 | 2.90e-05 | 85 | 202 | 8 | MM14746 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | MYO9B NHS FGD5 PREX1 ARHGAP21 RASGRF2 KALRN ARHGEF18 ARHGEF15 ARHGEF10 ARHGAP45 | 4.41e-05 | 175 | 202 | 11 | MM15599 |
| Pathway | PID_RHOA_REG_PATHWAY | 4.67e-05 | 46 | 202 | 6 | M68 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | MYO9B OBSCN FRS3 ARHGEF17 ARL13B TJP2 NHS FGD5 PREX1 ARHGAP21 RASGRF2 KALRN ARHGEF18 ARHGEF15 AKAP12 ARHGEF10 SCRIB ARHGAP45 | 6.20e-05 | 439 | 202 | 18 | MM15595 |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | OBSCN ARHGEF17 PREX1 MAGED1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 7.49e-05 | 154 | 202 | 10 | M27697 |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 1.51e-04 | 36 | 202 | 5 | M1315 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 3.23e-04 | 10 | 202 | 3 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 3.23e-04 | 10 | 202 | 3 | MM15073 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | MYO9B PREX1 ARHGAP21 RASGRF2 ARHGEF15 TIAM1 ARHGEF10 SCRIB ARHGAP45 | 3.95e-04 | 155 | 202 | 9 | M41808 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 3.99e-04 | 94 | 202 | 7 | MM15598 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 4.55e-04 | 69 | 202 | 6 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 4.92e-04 | 70 | 202 | 6 | M41806 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 4.92e-04 | 70 | 202 | 6 | MM15597 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYO9B OBSCN FRS3 ARHGEF17 ARL13B TJP2 NHS SGO2 FGD5 PREX1 ARHGAP21 RASGRF2 KALRN KLC2 ARHGEF18 ARHGEF15 AKAP12 TIAM1 ARHGEF10 SCRIB ARHGAP45 KDM1A | 6.60e-04 | 720 | 202 | 22 | M41838 |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 6.63e-04 | 74 | 202 | 6 | M41807 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SYNRG RIN3 LZTR1 GBF1 KMT2B MYO9B TMEM94 SPEG OBSCN CUL9 RNF40 ATG2A SRCAP BIRC6 ABCA7 PHLDB1 KCNH2 CLN3 KBTBD11 STRN4 ARC NAV1 HERC1 CHPF PREX1 ARHGAP21 RASAL1 COL1A1 KALRN POLE ZDHHC5 ICE1 SMG5 CEP192 ANO8 PIKFYVE GET4 SCAP ZNF341 SETD5 ZNF335 TNKS1BP1 AGRN AHNAK2 | 4.72e-18 | 1105 | 286 | 44 | 35748872 |
| Pubmed | LZTR1 ERCC6 AKAP8 MAP1A DNAJA2 BCL7C CUL9 CHD3 POGZ SRCAP ABCA7 TFPT BRD8 TELO2 EHMT2 ADGRL2 TAF11 DDX24 SAMD1 PHRF1 ZNF629 RNF213 PDCD2L CBX4 CREBBP UTP25 SETD5 MTIF2 SMARCA1 FIBP FMN2 ZFHX3 RERE MRGBP SCRIB KDM1A ZNF646 NIN | 1.48e-13 | 1116 | 286 | 38 | 31753913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES SYNRG GBF1 AKAP8 MAP1B SIK1 ARHGEF17 TTLL12 PHLDB1 NAV1 TJP2 NHS MAP4K4 ARHGAP21 BICC1 GOLGB1 KIF26B NTRK3 ROR2 ZNF629 KLC2 CEP192 CBX4 ALPK1 TIAM1 ARHGEF10 FMN2 TNKS1BP1 SCRIB DCLK1 EPB41L1 AHNAK2 | 1.48e-12 | 861 | 286 | 32 | 36931259 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GBF1 HK3 AKAP8 MAP1B MYO9B CUL9 POGZ GTF3C4 ZBTB37 BRD8 BHLHA15 FBXW5 ADGRL2 DDX24 FOXI1 FOXN1 SAMD1 PHF23 POLE REL SMG5 CREBBP ASH2L PELP1 ASMTL SMARCA1 MRGBP SCRIB TOP2B CUX1 KDM1A | 6.73e-12 | 857 | 286 | 31 | 25609649 |
| Pubmed | PDGFRB DNAJA2 SPTB CUL9 RNF40 POGZ GTF3C4 TTLL12 EHMT2 ARL13B ZBTB5 CHPF MAP4K4 PRRC2A PREX1 ARHGAP21 KPNA4 MAGED1 ANK2 KALRN TRIOBP POLE4 SMG5 CLIC6 CREBBP SLC4A3 TIAM1 ARHGEF10 MTIF2 AKR1C3 FIBP MAST1 FMN2 SCRIB TRIM37 SNTA1 DCLK1 CUX1 | 1.02e-11 | 1285 | 286 | 38 | 35914814 | |
| Pubmed | AKAP8 DNAJA2 CHD1 TTLL12 ABRAXAS2 TELO2 EHMT2 TEX264 ARL13B ASCC2 TMEM131L TACC1 ADGRL2 DDX24 MAP4K4 CLUH GOLGB1 MAGED1 HYOU1 ANK2 POLE ROR2 ZDHHC5 TRIOBP CEP192 AKAP12 PPM1G SLC4A2 MRPL4 LIFR COL18A1 TIAM1 ARHGEF10 MTIF2 LNPK SCRIB SMCR8 TOP2B CUX1 EPB41L1 NIN | 1.27e-11 | 1487 | 286 | 41 | 33957083 | |
| Pubmed | NES MAP1B NACA BCL7C AMER2 TELO2 STRN4 MAP4K4 ZC3HC1 AKAP12 ENAM PELP1 TNKS1BP1 LNPK SCRIB DCLK1 EPB41L1 | 2.93e-11 | 246 | 286 | 17 | 15345747 | |
| Pubmed | NCOA3 KMT2B AKAP8 DNAJA2 NACA BCL7C CUL9 CHD3 POGZ GPATCH8 SRCAP TFPT BRD8 EHMT2 HERC1 DDX24 PRRC2A FOXI1 MAGED1 PHF23 DHX37 ZNF629 PPP1R13B REL SMG5 CEP192 CREBBP ASH2L PPM1G MRPL4 ZSCAN18 SMARCA1 GMEB1 ZFHX3 RERE MRGBP CUX1 KDM1A | 2.17e-10 | 1429 | 286 | 38 | 35140242 | |
| Pubmed | TMEM94 SPEG CUL9 POGZ GPATCH8 ARHGEF17 RNF157 PHLDB1 NAV1 KATNIP MARCHF4 ARHGAP21 ZSWIM5 CEP192 IGDCC4 SETD5 MAST1 RERE SCRIB EPB41L1 | 2.38e-10 | 407 | 286 | 20 | 12693553 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ERCC6 KMT2B BCL7C CHD1 CHD3 POGZ GPATCH8 SRCAP GTF3C4 PWWP2A EHMT2 SGO2 DDX24 MIER2 SAMD1 DHX37 CBX4 PPM1G ZSCAN18 SMARCA1 MRGBP TOP2B CUX1 KDM1A | 3.20e-10 | 608 | 286 | 24 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 SYNRG GBF1 KMT2B AKAP8 BCL7C CHD3 POGZ GPATCH8 GTF3C4 BRD8 PTPRC CLN3 TJP2 HSF1 DDX24 MAP4K4 PRRC2A CLUH PHRF1 KLC2 DDX51 ZNF335 TNKS1BP1 RERE SCRIB TOP2B | 3.67e-10 | 774 | 286 | 27 | 15302935 |
| Pubmed | HK3 TMEM183A OBSCN CHD3 GPATCH8 SRCAP BRD8 PTPRC TEX264 TJP2 TMEM131L HERC1 ARHGAP21 BICC1 GOLGB1 ANAPC13 HYOU1 ARHGEF18 TMEM183BP CEP192 ASH2L AKAP12 COL18A1 SCAP ZNF341 SETD5 AKR1C3 FMN2 LNPK AGRN TRIM37 DCLK1 | 5.25e-10 | 1084 | 286 | 32 | 11544199 | |
| Pubmed | NES AKAP8 TMEM94 DNAJA2 NACA CHD1 RNF40 GPATCH8 BIRC6 GTF3C4 TEX264 NAV1 TJP2 TMEM131L TACC1 MAP4K4 CLUH MAGED1 HYOU1 ARHGEF18 RNF213 ICE1 SLC4A2 PIKFYVE SCAP ARHGEF10 | 5.57e-10 | 733 | 286 | 26 | 34672954 | |
| Pubmed | NACA RNF40 POGZ ATG2A TELO2 TECPR2 HECW2 KBTBD11 ANKIB1 ZBTB5 TMEM131L ADGRL2 MAP4K4 PHRF1 TRIOBP ICE1 SMG5 PLCH2 TNKS1BP1 KDM1A ZNF646 NIN | 6.86e-10 | 529 | 286 | 22 | 14621295 | |
| Pubmed | GBF1 BIRC6 PHLDB1 PREX1 PRUNE2 CUX2 TRIOBP SMG5 ALPK1 ARHGEF15 SCAP ARHGEF10 TNKS1BP1 SCRIB NIN | 7.16e-10 | 225 | 286 | 15 | 12168954 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 SYNRG MAP1A MYO9B DNAJA2 CUL9 RNF40 SRCAP NAV1 GOLGB1 MAGED1 ZNF629 KLC2 PPP1R13B CEP192 CBX4 CREBBP PPM1G PIKFYVE TNKS1BP1 TRIM37 KDM1A NIN | 9.03e-10 | 588 | 286 | 23 | 38580884 |
| Pubmed | KMT2B SRCAP ARHGEF17 TECPR2 ZBTB5 PRUNE2 ZNF629 ARHGEF10 DCLK1 EPB41L1 ZNF646 | 1.09e-09 | 104 | 286 | 11 | 9205841 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 ERCC6 CT47A1 SPEG OBSCN GTF3C4 KRBA1 PHLDB1 SCN9A ASCC2 TJP2 HERC1 DDX24 MAP4K4 ARHGAP21 KPNA4 RASGRF2 DHX37 KLC2 DNAI1 KDM1A | 1.28e-09 | 497 | 286 | 21 | 36774506 |
| Pubmed | 2.14e-09 | 43 | 286 | 8 | 12376548 | ||
| Pubmed | NCOA3 NES AKAP8 DNAJA2 EHMT2 STRN4 ARC NAV1 PPP1R3F MAP4K4 PRRC2A ARHGAP21 GOLGB1 RASAL1 SGIP1 MAGED1 ANK2 KALRN TRIOBP ARHGEF18 AKAP12 PELP1 ZSCAN18 SCRIB AGRN DCLK1 CUX1 KDM1A EPB41L1 | 2.30e-09 | 963 | 286 | 29 | 28671696 | |
| Pubmed | NCOA3 KMT2B RNF40 CHD3 POGZ BIRC6 GTF3C4 EHMT2 NAV1 ARHGAP21 GOLGB1 SAMD1 ICE1 POU5F1B ZFHX3 TNKS1BP1 RERE CUX1 KDM1A | 2.45e-09 | 418 | 286 | 19 | 34709266 | |
| Pubmed | NCOA3 LZTR1 CHD3 POGZ SRCAP ZBTB37 KRBA1 BRD8 BHLHA15 ZBTB5 HSF1 POU2F3 MIER2 CUX2 PHF23 ZSCAN5A ZDHHC5 POLE4 POU5F1B ZBTB7B ZSCAN5C GMEB1 ZFHX3 ZNF654 CUX1 ZNF646 | 4.22e-09 | 808 | 286 | 26 | 20412781 | |
| Pubmed | LZTR1 DNAJA2 PTEN BIRC6 ABRAXAS2 PTPN4 PTPRC TELO2 ARL13B NHS DMD HERC1 ADGRL2 PRRC2A KPNA4 HYOU1 ZDHHC5 TRIOBP PPP1R13B RNF213 CEP192 PTPRT PPM1G TIAM1 FMN2 SCRIB EPB41L1 TTC33 NIN | 1.52e-08 | 1049 | 286 | 29 | 27880917 | |
| Pubmed | TMEM94 BTN3A3 PHLDB1 ARL13B NHS DMD ADGRL2 MAP4K4 ARHGAP21 GOLGB1 ROR2 ZDHHC5 TRIOBP PPP1R13B AKAP12 ARHGEF10 SCRIB EPB41L1 | 1.67e-08 | 421 | 286 | 18 | 36976175 | |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 2.40e-08 | 38 | 286 | 7 | 11756498 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 MAP1B SPTB OBSCN CHD3 PTEN MAP3K12 PTPN4 PHLDB1 TECPR2 ANKIB1 NAV1 KATNIP GOLGB1 PRUNE2 ROR2 TRIOBP ARHGEF18 RNF213 TMEM183BP CEP192 CREBBP ANO8 PARP10 COL18A1 SETD5 ASMTL RASGEF1C MAST1 ZFHX3 BSCL2 RERE CUX1 EPB41L1 FRMD3 | 2.71e-08 | 1489 | 286 | 35 | 28611215 |
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 3.35e-08 | 60 | 286 | 8 | 12787561 | |
| Pubmed | GBF1 ARMCX2 BIRC6 ABRAXAS2 PWWP2A KRBA1 PREX1 MIER2 PRUNE2 ZNF629 ZDHHC5 ARHGEF18 RNF213 ALPK1 ARHGEF15 ANO8 PIKFYVE SCAP LNPK | 3.46e-08 | 493 | 286 | 19 | 15368895 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | CHD3 POGZ GTF3C4 EHMT2 ZBTB5 SAMD1 ZSCAN5A ZNF629 GMEB1 KDM1A | 9.33e-08 | 125 | 286 | 10 | 32891193 |
| Pubmed | ERCC6 KMT2B AKAP8 NACA CHD1 GPATCH8 PWWP2A TFPT BRD8 EHMT2 STRN4 ASCC2 PRRC2A PREX1 SDC1 GOLGB1 KPNA4 SAMD1 MAGED1 PHRF1 TRIOBP DDX51 ICE1 CBX4 ZBTB7B ASH2L COL18A1 UTP25 SETD5 ZFHX3 AGRN DCLK1 KDM1A EPB41L1 | 9.84e-08 | 1497 | 286 | 34 | 31527615 | |
| Pubmed | NES MAP1B CUL9 CHD1 POGZ BIRC6 TTLL12 TJP2 DDX24 PRRC2A CLUH HYOU1 DHX37 POLE PHRF1 DDX51 PPM1G UTP25 PELP1 TNKS1BP1 KDM1A | 1.39e-07 | 653 | 286 | 21 | 22586326 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SYNRG GBF1 AKAP8 MAP1A MAP1B DNAJA2 POGZ ASCC2 TJP2 ECI2 DDX24 PRRC2A CLUH MAGED1 HYOU1 DHX37 ZNF629 TRIOBP SMG5 AKAP12 TOP2B AHNAK2 | 1.84e-07 | 724 | 286 | 22 | 36232890 |
| Pubmed | MAP1A MAP1B AMER2 KBTBD11 STRN4 PRRC2A SGIP1 ANK2 ZDHHC5 FMN2 TNKS1BP1 LNPK SNTA1 DCLK1 EPB41L1 | 2.31e-07 | 347 | 286 | 15 | 17114649 | |
| Pubmed | TMEM131L NHS TACC1 MAP4K4 ARHGAP21 GOLGB1 MAGED1 HYOU1 ROR2 ZDHHC5 PPP1R13B SCRIB AHNAK2 | 3.29e-07 | 263 | 286 | 13 | 34702444 | |
| Pubmed | NCOA3 BCL7C CHD1 CHD3 ARMCX2 BIRC6 GTF3C4 EHMT2 KPNA4 MAGED1 POLE ASH2L PELP1 SMARCA1 TNKS1BP1 BSCL2 TOP2B | 4.34e-07 | 469 | 286 | 17 | 27634302 | |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 4.65e-07 | 36 | 286 | 6 | 26053890 | |
| Pubmed | 5.36e-07 | 116 | 286 | 9 | 30804394 | ||
| Pubmed | 5.50e-07 | 3 | 286 | 3 | 23152929 | ||
| Pubmed | The extracellular matrix protein agrin promotes heart regeneration in mice. | 5.50e-07 | 3 | 286 | 3 | 28581497 | |
| Pubmed | SYNRG KMT2B MAP1B POGZ SRCAP GTF3C4 BRD8 STRN4 TJP2 MAP4K4 PRRC2A PPP1R13B CREBBP ASH2L TNKS1BP1 SCRIB CUX1 KDM1A | 8.45e-07 | 549 | 286 | 18 | 38280479 | |
| Pubmed | GBF1 BIRC6 GTF3C4 ABRAXAS2 STRN4 NAV1 TJP2 MAP4K4 LNX2 MAGED1 IFFO1 KLC2 PPP1R13B CEP192 TRIM37 NIN | 1.09e-06 | 446 | 286 | 16 | 24255178 | |
| Pubmed | NCOA3 PTEN BLOC1S6 SYCE1 MIER2 MAGED1 IFFO1 NTRK3 PRR20A REL ZBTB7B GET4 ZNF341 ASMTL TRIM37 | 1.46e-06 | 402 | 286 | 15 | 24722188 | |
| Pubmed | 1.49e-06 | 131 | 286 | 9 | 31006538 | ||
| Pubmed | 2.19e-06 | 4 | 286 | 3 | 26751641 | ||
| Pubmed | Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis. | 2.19e-06 | 4 | 286 | 3 | 38172636 | |
| Pubmed | MAP1B RPS6KA1 NACA CHD3 TTLL12 ANKIB1 MAP4K4 ARHGAP21 MAGED1 HYOU1 DHX37 POLE ZNF629 ASH2L SLC4A2 MTIF2 SCRIB AGRN EPB41L1 | 2.27e-06 | 650 | 286 | 19 | 38777146 | |
| Pubmed | AKAP8 BIRC6 EHMT2 ARL13B KBTBD11 TJP2 TACC1 ADGRL2 ARHGAP21 GOLGB1 ZDHHC5 MUC16 ZC3HC1 RNF213 CEP192 AKAP12 PPM1G ZFHX3 SCRIB SMCR8 CUX1 | 2.28e-06 | 777 | 286 | 21 | 35844135 | |
| Pubmed | 2.29e-06 | 103 | 286 | 8 | 32744500 | ||
| Pubmed | NCOA3 BCL7C RNF40 CHD3 GTF3C4 BRD8 EHMT2 CREBBP ASH2L RERE CUX1 KDM1A | 2.62e-06 | 268 | 286 | 12 | 33640491 | |
| Pubmed | Mouse placenta fetal macrophages arise from endothelial cells outside the placenta. | 3.02e-06 | 13 | 286 | 4 | 36473461 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | KMT2B AKAP8 CHD3 POGZ PWWP2A TFPT PIGR EHMT2 FBXW5 PPP1R3F SAMD1 ZSCAN5A CBX4 ASH2L RERE KDM1A | 4.15e-06 | 495 | 286 | 16 | 27705803 |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | RNF40 POGZ EHMT2 PRR20E PIMREG TACC1 DMD SYCE1 MIER2 MAGED1 PRR20A REL CBX4 SLC7A7 ZBTB7B ARHGEF15 ZNF341 BSCL2 NUTM2F TRIM37 | 4.15e-06 | 742 | 286 | 20 | 26871637 |
| Pubmed | SPTB OBSCN PCDH12 ARMCX2 BIRC6 BNIP2 EHMT2 MYO18B ARHGAP21 ANK2 RASGRF2 KALRN LAMA4 ASH2L AKAP12 MYBPC2 | 4.37e-06 | 497 | 286 | 16 | 23414517 | |
| Pubmed | MYO9B CHD3 GTF3C4 NAV1 TACC1 ADGRL2 PRRC2A CREBBP ARHGEF10 SETD5 TNKS1BP1 SCRIB AHNAK2 | 4.39e-06 | 332 | 286 | 13 | 37433992 | |
| Pubmed | DNAJA2 CUL9 CHD3 BRD8 EHMT2 ZBTB5 SGO2 KPNA4 CBX4 MRPL4 PELP1 CUX1 | 4.42e-06 | 282 | 286 | 12 | 23667531 | |
| Pubmed | NCOA3 ERCC6 AKAP8 BRD8 EHMT2 TJP2 NHS DDX24 PRRC2A KALRN KLC2 ZC3HC1 GMEB1 TNKS1BP1 SCRIB EPB41L1 | 5.08e-06 | 503 | 286 | 16 | 16964243 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | LZTR1 TMEM94 PHLDB1 AMER2 ARL13B NAV1 MAP4K4 SDC1 ARHGAP21 ANK2 UBXN6 ZDHHC5 SLC4A2 FMN2 SCRIB EPB41L1 PSD4 | 5.88e-06 | 569 | 286 | 17 | 30639242 |
| Pubmed | 7.49e-06 | 57 | 286 | 6 | 18022353 | ||
| Pubmed | NES MAP1A MAP1B DNAJA2 SPTB CHD3 ARHGEF17 PHLDB1 HECW2 KBTBD11 STRN4 NAV1 TJP2 DMD PRRC2A ARHGAP21 RASAL1 SGIP1 HYOU1 ANK2 KALRN KLC2 ZC3HC1 MAST1 TNKS1BP1 SCRIB SNTA1 DCLK1 EPB41L1 | 8.39e-06 | 1431 | 286 | 29 | 37142655 | |
| Pubmed | NES NACA CHD1 ARHGEF17 ABRAXAS2 TJP2 FGD5 DMD PRRC2A PREX1 ARHGAP21 MAGED1 RASGRF2 ARHGEF18 ASH2L ARHGEF15 PPM1G MRPL4 TIAM1 ARHGEF10 SCRIB KDM1A | 8.51e-06 | 916 | 286 | 22 | 32203420 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 9.17e-06 | 59 | 286 | 6 | 28813667 | |
| Pubmed | AKAP8 TMEM183A MAP1B DNAJA2 NACA IRF7 ZBP1 TELO2 ASCC2 TJP2 ADGRL2 DDX24 PRRC2A ALPP SECTM1 MAGED1 HYOU1 TRIOBP RNF213 PPM1G MRPL4 LIFR PELP1 TNKS1BP1 LNPK SCRIB TOP2B CUX1 AHNAK2 | 9.43e-06 | 1440 | 286 | 29 | 30833792 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TMEM94 BIRC6 TELO2 NAV1 HERC1 MAP4K4 ARHGAP21 MAGED1 ZDHHC5 KLC2 PDCD2L CEP192 SLC7A7 AKAP12 ARHGEF10 MFSD8 SCRIB AGRN EPB41L1 | 9.56e-06 | 719 | 286 | 19 | 35337019 |
| Pubmed | ERCC6 KMT2B CHD3 ABRAXAS2 PTPRC ASCC2 HERC1 CHPF GOLGB1 LAMA4 PPP1R13B CBX4 CREBBP ASH2L PELP1 ZNF341 GMEB1 | 9.62e-06 | 591 | 286 | 17 | 15231748 | |
| Pubmed | SYNRG MAP1A MAP1B DNAJA2 NACA PTEN BIRC6 AMER2 STRN4 NAV1 TJP2 TACC1 MAP4K4 RASAL1 SGIP1 MAGED1 ANK2 KALRN KLC2 TRIOBP ANO8 PPM1G LNPK DCLK1 EPB41L1 | 9.64e-06 | 1139 | 286 | 25 | 36417873 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | KMT2B AKAP8 DNAJA2 RNF40 CHD3 POGZ GPATCH8 SRCAP GTF3C4 PWWP2A TFPT BRD8 EHMT2 DDX24 SAMD1 ZSCAN5A PHRF1 ZNF629 DDX51 CBX4 ZBTB7B ASH2L PELP1 MRGBP TOP2B CUX1 KDM1A | 1.04e-05 | 1294 | 286 | 27 | 30804502 |
| Pubmed | 1.08e-05 | 6 | 286 | 3 | 12149647 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | CUL9 CHD1 HECW2 STRN4 ECI2 MAP4K4 HYOU1 DHX37 PDCD2L TNKS1BP1 | 1.15e-05 | 212 | 286 | 10 | 33853758 |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 1.28e-05 | 37 | 286 | 5 | 27565344 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.41e-05 | 95 | 286 | 7 | 29643511 | |
| Pubmed | ZNF142 MAP1A POGZ CCDC88B BLOC1S6 NAV1 DMD MAP4K4 GOLGB1 KPNA4 KIF26B LAMA4 PPP1R13B CREBBP CUX1 | 1.43e-05 | 486 | 286 | 15 | 20936779 | |
| Pubmed | Mutation of ARHGAP9 in patients with coronary spastic angina. | 1.46e-05 | 38 | 286 | 5 | 19911011 | |
| Pubmed | 1.47e-05 | 64 | 286 | 6 | 22261194 | ||
| Pubmed | Functional consequences of necdin nucleocytoplasmic localization. | 1.47e-05 | 64 | 286 | 6 | 22442722 | |
| Pubmed | DNAJA2 NACA DACT2 RNF40 PHLDB1 EHMT2 FGD5 DMD HSF1 DDX24 ARHGAP21 GOLGB1 KPNA4 DHX37 CREBBP ARHGEF15 PPM1G SCAP KDM1A | 1.85e-05 | 754 | 286 | 19 | 35906200 | |
| Pubmed | 1.88e-05 | 7 | 286 | 3 | 2968981 | ||
| Pubmed | EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation. | 1.88e-05 | 7 | 286 | 3 | 30008323 | |
| Pubmed | Regulation of transcription by the MLL2 complex and MLL complex-associated AKAP95. | 1.88e-05 | 7 | 286 | 3 | 23995757 | |
| Pubmed | 1.88e-05 | 7 | 286 | 3 | 22044751 | ||
| Pubmed | A genome-wide association study of early menopause and the combined impact of identified variants. | 1.88e-05 | 7 | 286 | 3 | 23307926 | |
| Pubmed | 1.92e-05 | 67 | 286 | 6 | 29254152 | ||
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | GBF1 MAP1B GPATCH8 PRRC2A MAGED1 TRIOBP REL SMG5 PPM1G MRPL4 | 1.99e-05 | 226 | 286 | 10 | 25900982 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ERCC6 AKAP8 MAP1B MYO9B DNAJA2 NACA CHD3 BIRC6 GTF3C4 SGO2 DDX24 PRRC2A SAMD1 DHX37 POLE ZNF629 DDX51 PELP1 TOP2B | 2.02e-05 | 759 | 286 | 19 | 35915203 |
| Pubmed | 2.10e-05 | 101 | 286 | 7 | 10997877 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SYNRG MAP1A MAP1B RNF40 GTF3C4 PIGR ZBTB5 HSF1 MAGED1 CBX4 CREBBP TNKS1BP1 TOP2B AHNAK2 | 2.18e-05 | 444 | 286 | 14 | 34795231 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | MAP1A MAP1B SPEG AMER2 TJP2 PRRC2A SGIP1 TIAM1 DCLK1 EPB41L1 | 2.40e-05 | 231 | 286 | 10 | 16452087 |
| Pubmed | 2.41e-05 | 42 | 286 | 5 | 35705031 | ||
| Pubmed | NCOA3 SCN9A ANKIB1 PPP1R3F HSF1 KALRN AKAP12 PIKFYVE PARP10 MAST1 | 2.58e-05 | 233 | 286 | 10 | 37704626 | |
| Pubmed | PDGFRB ZNF391 MYO9B TMEM94 SPTB OBSCN CHD1 GPATCH8 ARMCX2 PWWP2A ERP27 EHMT2 LIPT2 ANAPC13 ANK2 ZSWIM5 KLC2 REL COL18A1 SCAP ARHGEF10 MFSD8 ARHGAP45 AGRN TRIM37 | 2.82e-05 | 1215 | 286 | 25 | 15146197 | |
| Pubmed | Chromosomal location of the murine anion exchanger genes encoding AE2 and AE3. | 2.99e-05 | 8 | 286 | 3 | 7894173 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.00e-05 | 146 | 286 | 8 | 23892456 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GBF1 RPS6KA1 NACA BIRC6 GTF3C4 TTLL12 ABRAXAS2 BNIP2 TELO2 STRN4 TJP2 HERC1 HSF1 CLUH RASAL1 KPNA4 PRUNE2 HYOU1 KLC2 ZC3HC1 AKAP12 PPM1G GET4 ARHGEF10 ASMTL TNKS1BP1 EPB41L1 AHNAK2 | 3.05e-05 | 1455 | 286 | 28 | 22863883 |
| Pubmed | 3.17e-05 | 191 | 286 | 9 | 20195357 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | AKAP8 DNAJA2 NACA C11orf24 POGZ GTF3C4 TTLL12 BRD8 PIGR EHMT2 STRN4 SGO2 HSF1 ANAPC13 ALPP KPNA4 TRIOBP CEP192 AKAP12 TNKS1BP1 SCRIB TOP2B KDM1A TTC33 | 3.51e-05 | 1155 | 286 | 24 | 20360068 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG MAP1A MAP1B NACA CHD1 CHD3 SRCAP GTF3C4 TACC1 PRRC2A ARHGAP21 GOLGB1 ANK2 ICE1 PDCD2L AKAP12 TNKS1BP1 SCRIB SMCR8 TOP2B AHNAK2 | 3.59e-05 | 934 | 286 | 21 | 33916271 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.64e-05 | 150 | 286 | 8 | 28242625 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | MAP1B ZSCAN25 DDX24 SDC1 SAMD1 DDX51 PPM1G COL18A1 PELP1 SMARCA1 AGRN ZNF646 | 3.68e-05 | 349 | 286 | 12 | 25665578 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA3 KMT2B BCL7C POGZ EHMT2 HYOU1 CREBBP ASH2L SMARCA1 ZFHX3 RERE KDM1A | 3.89e-05 | 351 | 286 | 12 | 38297188 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | DNAJA2 RNF40 GPATCH8 DMD DHX37 ARHGEF18 CREBBP MACROD2 RASGEF1C | 4.04e-05 | 197 | 286 | 9 | 20811636 |
| Pubmed | GBF1 AKAP8 PDGFRB MYO9B RNF40 CCDC88B BIRC6 BTN3A3 PTPRC ECI2 DDX24 PRRC2A GOLGB1 HYOU1 PHRF1 ZDHHC5 KLC2 RNF213 DDX51 PDCD2L SLC4A2 PELP1 ARHGAP45 PSD4 | 4.18e-05 | 1168 | 286 | 24 | 19946888 | |
| Interaction | TOP3B interactions | SYNRG RIN3 LZTR1 GBF1 KMT2B MYO9B TMEM94 SPEG DNAJA2 SPTB OBSCN CUL9 RNF40 ATG2A SRCAP BIRC6 ABCA7 PHLDB1 KCNH2 CLN3 KBTBD11 STRN4 ARC NAV1 HERC1 CHPF PRRC2A PREX1 ARHGAP21 RASAL1 COL1A1 HYOU1 KALRN POLE ZDHHC5 ICE1 SMG5 CEP192 ANO8 PIKFYVE GET4 SCAP PELP1 ZNF341 SETD5 ZNF335 TNKS1BP1 AGRN AHNAK2 | 6.79e-09 | 1470 | 278 | 49 | int:TOP3B |
| Interaction | NCK2 interactions | LZTR1 PDGFRB PRR20C PRR20D PRR20B PRR20E TJP2 NHS MAP4K4 PRRC2A ARHGAP21 NTRK3 KLC2 PRR20A REL ZBTB7B ZNF341 NUTM2F | 2.70e-08 | 262 | 278 | 18 | int:NCK2 |
| Interaction | ZNF683 interactions | 1.15e-07 | 10 | 278 | 5 | int:ZNF683 | |
| Interaction | YWHAH interactions | NCOA3 NES SYNRG RIN3 GBF1 AKAP8 SPEG RPS6KA1 SIK1 ARHGEF17 PTPN4 PHLDB1 KCNH2 NAV1 TJP2 NHS HERC1 MARCHF4 MAP4K4 ARHGAP21 BICC1 KIF26B ROR2 ZNF629 KLC2 CEP192 CBX4 CREBBP TIAM1 MAST1 FMN2 MTBP TNKS1BP1 SCRIB DCLK1 EPB41L1 AHNAK2 NIN | 1.82e-07 | 1102 | 278 | 38 | int:YWHAH |
| Interaction | CELF4 interactions | 2.08e-07 | 11 | 278 | 5 | int:CELF4 | |
| Interaction | BEND2 interactions | 3.53e-07 | 12 | 278 | 5 | int:BEND2 | |
| Interaction | H2BC21 interactions | RIN3 KMT2B SPANXN2 MAP1B OBSCN SIK1 RNF40 POGZ SRCAP PWWP2A EHMT2 SGO2 HSF1 MAP4K4 PRRC2A SAMD1 SMG5 CBX4 CREBBP ASH2L PPM1G PARP10 PELP1 SMARCA1 MTBP MRGBP TOP2B KDM1A | 4.39e-07 | 696 | 278 | 28 | int:H2BC21 |
| Interaction | FOXG1 interactions | 7.65e-07 | 95 | 278 | 10 | int:FOXG1 | |
| Interaction | PTTG2 interactions | 8.71e-07 | 14 | 278 | 5 | int:PTTG2 | |
| Interaction | CSNK2A1 interactions | BDP1 RIN3 GBF1 KMT2B AKAP8 NACA CUL9 CHD3 ZSCAN25 PTEN BIRC6 PTPN4 TFPT PTPRC EHMT2 HECW2 PPP1R1B HSF1 DDX24 KPNA4 CUX2 ZSCAN5A PHRF1 REL CBX4 ZBTB7B CREBBP ASH2L MRPL4 FIBP MAST1 TNKS1BP1 KDM1A | 1.24e-06 | 956 | 278 | 33 | int:CSNK2A1 |
| Interaction | GOLGA1 interactions | LZTR1 GBF1 BIRC6 STRN4 NAV1 SYCE1 GOLGB1 PPP1R13B CEP192 SCAP TNKS1BP1 SMCR8 AHNAK2 | 1.65e-06 | 183 | 278 | 13 | int:GOLGA1 |
| Interaction | MBNL3 interactions | 1.86e-06 | 16 | 278 | 5 | int:MBNL3 | |
| Interaction | FBXO22 interactions | BDP1 ERCC6 CT47A1 SPEG OBSCN SIK1 PTEN GTF3C4 KRBA1 PHLDB1 SCN9A ASCC2 TJP2 HERC1 DDX24 MAP4K4 ARHGAP21 KPNA4 RASGRF2 DHX37 KLC2 DNAI1 KDM1A | 1.91e-06 | 540 | 278 | 23 | int:FBXO22 |
| Interaction | SP4 interactions | 2.98e-06 | 46 | 278 | 7 | int:SP4 | |
| Interaction | TLX3 interactions | NCOA3 POGZ PRR20C PRR20D PRR20B EHMT2 PRR20E DDX24 MAGED1 ROR2 PRR20A REL ZFHX3 RERE SNTA1 CUX1 | 3.13e-06 | 291 | 278 | 16 | int:TLX3 |
| Interaction | CXADR interactions | DNAJA2 PTEN TEX264 ARL13B TJP2 TACC1 ADGRL2 MAP4K4 GOLGB1 LNX2 ROR2 UBXN6 ZDHHC5 PPP1R13B ARHGEF10 SCRIB SMCR8 EPB41L1 | 4.10e-06 | 369 | 278 | 18 | int:CXADR |
| Interaction | ZFPL1 interactions | GBF1 ARL13B TACC1 ADGRL2 MAP4K4 ARHGAP21 GOLGB1 ROR2 ZDHHC5 PPP1R13B AKAP12 SLC4A2 TIAM1 TNKS1BP1 SCRIB SMCR8 CUX1 EPB41L1 FRMD3 AHNAK2 | 4.54e-06 | 448 | 278 | 20 | int:ZFPL1 |
| Interaction | OCLN interactions | PHLDB1 ARL13B TJP2 NHS ADGRL2 MAP4K4 SDC1 ARHGAP21 GOLGB1 ANK2 KIF26B ROR2 ZDHHC5 PPP1R13B AKAP12 SLC4A2 TIAM1 FMN2 TNKS1BP1 SCRIB EPB41L1 | 6.70e-06 | 500 | 278 | 21 | int:OCLN |
| Interaction | HNF4A interactions | NCOA3 KMT2B BCL7C CHD3 POGZ SRCAP BRD8 EHMT2 DMD ZNF629 MUC19 CREBBP ASH2L CUX1 KDM1A | 7.02e-06 | 275 | 278 | 15 | int:HNF4A |
| Interaction | PRR34 interactions | 8.18e-06 | 21 | 278 | 5 | int:PRR34 | |
| Interaction | TPRX1 interactions | 8.18e-06 | 21 | 278 | 5 | int:TPRX1 | |
| Interaction | PRR20E interactions | 1.10e-05 | 101 | 278 | 9 | int:PRR20E | |
| Interaction | SFN interactions | SYNRG GBF1 MAP1A MAP1B ARHGEF17 PHLDB1 NAV1 TJP2 NHS DDX24 MAP4K4 ARHGAP21 LNX2 KIF26B NTRK3 ROR2 ZNF629 KLC2 CEP192 CBX4 TIAM1 ARHGEF10 FMN2 SCRIB AHNAK2 | 1.22e-05 | 692 | 278 | 25 | int:SFN |
| Interaction | MAGED1 interactions | RIN3 DNAJA2 PRR20C PRR20D PRR20B TELO2 PRR20E FBXW5 PRRC2A FOXI1 MAGED1 ROR2 PRR20A CEP192 AGRN | 1.62e-05 | 295 | 278 | 15 | int:MAGED1 |
| Interaction | H3-3A interactions | ERCC6 KMT2B BCL7C CHD1 CHD3 POGZ GPATCH8 SRCAP GTF3C4 PWWP2A EHMT2 KPNA4 SAMD1 DHX37 CBX4 CREBBP PPM1G PARP10 TIAM1 PELP1 ZSCAN18 SMARCA1 MRGBP TOP2B CUX1 KDM1A | 1.62e-05 | 749 | 278 | 26 | int:H3-3A |
| Interaction | H2BC8 interactions | KMT2B BCL7C CHD1 CHD3 POGZ SRCAP GTF3C4 PWWP2A BRD8 EHMT2 SGO2 DHX37 ZNF629 ZC3HC1 CBX4 ASH2L PPM1G SMARCA1 MRGBP TOP2B CUX1 KDM1A | 1.78e-05 | 576 | 278 | 22 | int:H2BC8 |
| Interaction | RAPGEF5 interactions | 1.82e-05 | 60 | 278 | 7 | int:RAPGEF5 | |
| Interaction | PRR35 interactions | 1.91e-05 | 83 | 278 | 8 | int:PRR35 | |
| Interaction | H3C3 interactions | KMT2B CHD1 CHD3 POGZ SRCAP GTF3C4 PWWP2A EHMT2 SGO2 DDX24 MIER2 SAMD1 DHX37 CBX4 ZSCAN18 SMARCA1 MRGBP TOP2B CUX1 KDM1A | 1.95e-05 | 495 | 278 | 20 | int:H3C3 |
| Interaction | TBX6 interactions | 1.96e-05 | 41 | 278 | 6 | int:TBX6 | |
| Interaction | EIF4ENIF1 interactions | PRR20C PRR20D PRR20B EHMT2 PRR20E HSF1 PRRC2A BICC1 DHX37 PRR20A SMG5 CEP192 CREBBP KDM1A NIN | 1.97e-05 | 300 | 278 | 15 | int:EIF4ENIF1 |
| Interaction | PRR20A interactions | 2.03e-05 | 109 | 278 | 9 | int:PRR20A | |
| Interaction | GJA1 interactions | GBF1 MAP1B DNAJA2 GPR182 TEX264 ARL13B TJP2 TACC1 ADGRL2 MAP4K4 ARHGAP21 GOLGB1 KALRN ROR2 ZDHHC5 PPM1G SLC4A2 TIAM1 ARHGEF10 SCRIB SMCR8 EPB41L1 | 2.14e-05 | 583 | 278 | 22 | int:GJA1 |
| Interaction | FAM222B interactions | 2.26e-05 | 42 | 278 | 6 | int:FAM222B | |
| Interaction | INSYN1 interactions | RNF40 BIRC6 BLOC1S6 TFPT ARC DMD MAP4K4 KLC2 TRIOBP SNTA1 NIN | 2.38e-05 | 169 | 278 | 11 | int:INSYN1 |
| Interaction | C3orf36 interactions | 2.50e-05 | 26 | 278 | 5 | int:C3orf36 | |
| Interaction | CAV1 interactions | GBF1 PDGFRB PTEN TTLL12 ARL13B STRN4 ADGRL2 MAP4K4 ARHGAP21 GOLGB1 ROR2 UBXN6 ZDHHC5 AKAP12 PPM1G SLC4A2 TIAM1 FMN2 TNKS1BP1 SCRIB SMCR8 TRIM37 CUX1 EPB41L1 AHNAK2 | 2.59e-05 | 724 | 278 | 25 | int:CAV1 |
| Interaction | SAMD11 interactions | 2.59e-05 | 43 | 278 | 6 | int:SAMD11 | |
| Interaction | BICRAL interactions | 2.59e-05 | 43 | 278 | 6 | int:BICRAL | |
| Interaction | DMRT3 interactions | 2.70e-05 | 87 | 278 | 8 | int:DMRT3 | |
| Interaction | PHF1 interactions | NCOA3 CHD3 PWWP2A PRR20C PRR20D PRR20B PRR20E MAGED1 PRR20A SMARCA1 KDM1A | 2.80e-05 | 172 | 278 | 11 | int:PHF1 |
| Interaction | C10orf55 interactions | 3.10e-05 | 65 | 278 | 7 | int:C10orf55 | |
| Interaction | PRR20B interactions | 3.46e-05 | 90 | 278 | 8 | int:PRR20B | |
| Interaction | PRR20C interactions | 3.46e-05 | 90 | 278 | 8 | int:PRR20C | |
| Interaction | PRR20D interactions | 3.46e-05 | 90 | 278 | 8 | int:PRR20D | |
| Interaction | BHLHE40 interactions | 4.09e-05 | 119 | 278 | 9 | int:BHLHE40 | |
| Interaction | KRTAP19-1 interactions | 4.36e-05 | 47 | 278 | 6 | int:KRTAP19-1 | |
| Interaction | CHAF1A interactions | LZTR1 AKAP8 CHD3 POGZ PWWP2A EHMT2 TJP2 REL CREBBP AKAP12 PPM1G PELP1 SMARCA1 TOP2B KDM1A | 4.45e-05 | 322 | 278 | 15 | int:CHAF1A |
| Interaction | TCF7L2 interactions | PRR20C TFPT PRR20D PRR20B PRR20E FOXI1 UBXN6 PRR20A ZBTB7B CREBBP LIFR SLC6A13 PELP1 CUX1 | 4.51e-05 | 285 | 278 | 14 | int:TCF7L2 |
| Interaction | RBM23 interactions | 4.73e-05 | 94 | 278 | 8 | int:RBM23 | |
| Interaction | ARHGEF10 interactions | 5.11e-05 | 95 | 278 | 8 | int:ARHGEF10 | |
| Interaction | HIVEP1 interactions | POGZ PRR20C PRR20D PRR20B PRR20E MAGED1 ROR2 PRR20A CREBBP ZFHX3 KDM1A | 5.73e-05 | 186 | 278 | 11 | int:HIVEP1 |
| Interaction | CSNK2A2 interactions | ERCC6 NACA PTEN GTF3C4 TTLL12 PTPN4 TFPT PTPRC PIGR PPP1R1B STRN4 SGO2 DDX24 ZSCAN5A PHRF1 CBX4 ZBTB7B CREBBP ASH2L PPM1G PELP1 MAST1 KDM1A AHNAK2 | 6.29e-05 | 718 | 278 | 24 | int:CSNK2A2 |
| Interaction | ENTR1 interactions | DNAJA2 CHD3 ABRAXAS2 TFPT TJP2 ARHGAP21 KLC2 PPP1R13B CEP192 KDM1A NIN | 6.32e-05 | 188 | 278 | 11 | int:ENTR1 |
| Interaction | RHOF interactions | GBF1 PDGFRB MYO9B TELO2 ARL13B ADGRL2 MAP4K4 ARHGAP21 GOLGB1 KIF26B ROR2 ZDHHC5 TRIOBP AKAP12 PPM1G SLC4A2 PIKFYVE TIAM1 FIBP FMN2 SCRIB TOP2B EPB41L1 | 6.43e-05 | 673 | 278 | 23 | int:RHOF |
| Interaction | ZNF385C interactions | 8.33e-05 | 33 | 278 | 5 | int:ZNF385C | |
| Interaction | LCK interactions | RIN3 DNAJA2 PTPRC ARL13B NAV1 MAP4K4 ARHGAP21 GOLGB1 KALRN ROR2 UBXN6 ZDHHC5 PPP1R13B FMN2 TNKS1BP1 SCRIB EPB41L1 AHNAK2 | 8.34e-05 | 463 | 278 | 18 | int:LCK |
| Interaction | SP7 interactions | NCOA3 KMT2B AKAP8 BCL7C CHD3 POGZ GPATCH8 EHMT2 DDX24 CREBBP ASH2L RERE CUX1 KDM1A | 9.01e-05 | 304 | 278 | 14 | int:SP7 |
| Interaction | C1orf94 interactions | 9.09e-05 | 103 | 278 | 8 | int:C1orf94 | |
| Interaction | ESRP1 interactions | 9.30e-05 | 77 | 278 | 7 | int:ESRP1 | |
| Interaction | MYB interactions | 9.74e-05 | 133 | 278 | 9 | int:MYB | |
| Interaction | SYNGAP1 interactions | MAP1A MAP1B PDGFRB BIRC6 KBTBD11 ARC ARHGAP21 RASAL1 LNX2 SGIP1 ANK2 KALRN NTRK3 EPB41L1 | 1.00e-04 | 307 | 278 | 14 | int:SYNGAP1 |
| Interaction | VEZF1 interactions | 1.04e-04 | 105 | 278 | 8 | int:VEZF1 | |
| Interaction | RIPPLY1 interactions | 1.07e-04 | 55 | 278 | 6 | int:RIPPLY1 | |
| Interaction | FLOT1 interactions | DNAJA2 ARL13B FGD5 ADGRL2 MAP4K4 ARHGAP21 ANK2 ROR2 UBXN6 ZDHHC5 PPP1R13B AKAP12 TIAM1 FMN2 TNKS1BP1 SCRIB EPB41L1 NIN | 1.15e-04 | 475 | 278 | 18 | int:FLOT1 |
| Interaction | KDM1A interactions | NCOA3 KMT2B RNF40 CHD3 POGZ PTEN BIRC6 GTF3C4 ZBP1 EHMT2 ASCC2 NAV1 TACC1 ECI2 HSF1 ARHGAP21 GOLGB1 SAMD1 ZSCAN5A ICE1 PELP1 ZFHX3 TNKS1BP1 RERE CUX1 KDM1A TTC33 NIN | 1.15e-04 | 941 | 278 | 28 | int:KDM1A |
| Interaction | ANK1 interactions | 1.19e-04 | 56 | 278 | 6 | int:ANK1 | |
| Interaction | GTF3C2 interactions | SPANXN2 DNAJA2 PTEN GTF3C4 PRR20E HSF1 UBXN6 PRR20A DDX51 KDM1A | 1.24e-04 | 169 | 278 | 10 | int:GTF3C2 |
| Interaction | SH3RF1 interactions | 1.27e-04 | 108 | 278 | 8 | int:SH3RF1 | |
| Interaction | EPS15L1 interactions | 1.29e-04 | 138 | 278 | 9 | int:EPS15L1 | |
| Interaction | FOXH1 interactions | 1.35e-04 | 109 | 278 | 8 | int:FOXH1 | |
| Interaction | KRT8 interactions | NES CHD3 BIRC6 STRN4 NAV1 FGD5 DMD DDX24 CLUH ARHGAP21 ZDHHC5 PPP1R13B CEP192 TRIM37 CUX1 TTC33 NIN | 1.45e-04 | 441 | 278 | 17 | int:KRT8 |
| Interaction | TRIP6 interactions | RIN3 PDGFRB FRS3 TTLL12 ZBP1 TJP2 HSF1 DHX37 NTRK3 ROR2 RNF213 RERE SCRIB TRIM37 DCLK1 | 1.45e-04 | 358 | 278 | 15 | int:TRIP6 |
| Interaction | HLX interactions | 1.46e-04 | 37 | 278 | 5 | int:HLX | |
| Interaction | ZCCHC14 interactions | 1.46e-04 | 37 | 278 | 5 | int:ZCCHC14 | |
| Interaction | TNRC6A interactions | NES KMT2B ABRAXAS2 TJP2 PRRC2A SMG5 CEP192 ASH2L TNKS1BP1 TRIM37 KDM1A AHNAK2 NIN | 1.48e-04 | 280 | 278 | 13 | int:TNRC6A |
| Interaction | FOXQ1 interactions | 1.52e-04 | 141 | 278 | 9 | int:FOXQ1 | |
| Interaction | YWHAZ interactions | BDP1 SYNRG RIN3 GBF1 AKAP8 SPEG SIK1 PTPN4 PHLDB1 NAV1 TJP2 NHS KATNIP HSF1 DDX24 PRRC2A ARHGAP21 LNX2 RASGRF2 KIF26B ROR2 ZNF629 KLC2 ARHGEF18 CEP192 CBX4 TIAM1 MAST1 MTBP SCRIB TRIM37 DCLK1 EPB41L1 PSD4 NIN | 1.54e-04 | 1319 | 278 | 35 | int:YWHAZ |
| Interaction | FAM9A interactions | 1.59e-04 | 59 | 278 | 6 | int:FAM9A | |
| Interaction | SNTB2 interactions | 1.69e-04 | 143 | 278 | 9 | int:SNTB2 | |
| Interaction | EPHA2 interactions | PDGFRB TMEM94 PTEN BTN3A3 PHLDB1 ARL13B NHS DMD ADGRL2 MAP4K4 SDC1 ARHGAP21 GOLGB1 NTRK3 ROR2 ZDHHC5 TRIOBP PPP1R13B AKAP12 TIAM1 ARHGEF10 SCRIB EPB41L1 | 1.71e-04 | 719 | 278 | 23 | int:EPHA2 |
| Interaction | LYN interactions | PTPRC ARL13B DMD ADGRL2 MAP4K4 ARHGAP21 PRUNE2 ANK2 KIF26B ROR2 ZDHHC5 KLC2 PPP1R13B CREBBP AKAP12 TIAM1 SMARCA1 FMN2 TNKS1BP1 SCRIB TOP2B EPB41L1 AHNAK2 | 1.74e-04 | 720 | 278 | 23 | int:LYN |
| Interaction | YWHAQ interactions | NCOA3 SYNRG RIN3 GBF1 SPEG RPS6KA1 SPTB SIK1 MAP3K12 PTPN4 PHLDB1 NAV1 TJP2 NHS FGD5 HSF1 DDX24 ARHGAP21 BICC1 GOLGB1 KIF26B ROR2 ZNF629 KLC2 CEP192 CBX4 TIAM1 SCRIB TRIM37 DCLK1 EPB41L1 | 1.75e-04 | 1118 | 278 | 31 | int:YWHAQ |
| Interaction | RTL9 interactions | 1.76e-04 | 21 | 278 | 4 | int:RTL9 | |
| Interaction | CHTOP interactions | GBF1 SPTB CHD3 PTEN BRD8 BHLHA15 HECW2 HSF1 PELP1 MTIF2 MAST1 | 1.83e-04 | 212 | 278 | 11 | int:CHTOP |
| Interaction | FBXO38 interactions | 1.88e-04 | 145 | 278 | 9 | int:FBXO38 | |
| Interaction | CABP2 interactions | 1.92e-04 | 61 | 278 | 6 | int:CABP2 | |
| Interaction | ARID5A interactions | PRR20C PRR20D PRR20B PRR20E POU2F3 MAGED1 ROR2 PRR20A CREBBP | 2.08e-04 | 147 | 278 | 9 | int:ARID5A |
| Interaction | LGALS1 interactions | RIN3 CDHR2 PTEN PTPRC PIGR FBXW5 CLUH NTRK3 LAMA4 MUC16 POLE4 SLC4A2 IGDCC4 TRIM37 | 2.26e-04 | 332 | 278 | 14 | int:LGALS1 |
| Interaction | NEUROG3 interactions | 2.31e-04 | 149 | 278 | 9 | int:NEUROG3 | |
| Interaction | TLE3 interactions | NCOA3 AKAP8 GPATCH8 BRD8 FOXI1 COL1A1 MAGED1 CREBBP PPM1G ZSCAN18 ZFHX3 TNKS1BP1 RERE CUX1 KDM1A | 2.47e-04 | 376 | 278 | 15 | int:TLE3 |
| Interaction | DAZAP2 interactions | POGZ PRR20C PRR20D PRR20B PRR20E DESI1 MAGED1 ROR2 UBXN6 PRR20A | 2.70e-04 | 186 | 278 | 10 | int:DAZAP2 |
| Interaction | PARD3 interactions | ARL13B TJP2 ADGRL2 MAP4K4 ARHGAP21 KPNA4 NTRK3 ROR2 ZDHHC5 PPP1R13B ARHGEF18 TIAM1 SCRIB | 2.72e-04 | 298 | 278 | 13 | int:PARD3 |
| Interaction | TNIK interactions | NES EHMT2 STRN4 ARC MAP4K4 ARHGAP21 ANK2 KALRN NTRK3 ROR2 PPP1R13B ZSCAN18 AGRN DCLK1 KDM1A | 2.84e-04 | 381 | 278 | 15 | int:TNIK |
| Interaction | FBLN2 interactions | 2.96e-04 | 66 | 278 | 6 | int:FBLN2 | |
| Interaction | DIRAS3 interactions | HERC1 ADGRL2 MAP4K4 ARHGAP21 ROR2 ZDHHC5 PPM1G TIAM1 MTIF2 FMN2 SCRIB EPB41L1 | 2.99e-04 | 262 | 278 | 12 | int:DIRAS3 |
| Interaction | RERE interactions | 3.04e-04 | 93 | 278 | 7 | int:RERE | |
| Interaction | RNF43 interactions | AKAP8 OBSCN ABRAXAS2 TMEM131L NHS TACC1 MAP4K4 ARHGAP21 GOLGB1 MAGED1 HYOU1 ROR2 ZDHHC5 PPP1R13B SCRIB AHNAK2 | 3.11e-04 | 427 | 278 | 16 | int:RNF43 |
| Interaction | NCOR2 interactions | NCOA3 PTEN ZBTB5 FOXI1 KPNA4 SGIP1 ZSCAN5A ZBTB7B CREBBP AGRN TRIM37 KDM1A | 3.21e-04 | 264 | 278 | 12 | int:NCOR2 |
| Interaction | SMAP1 interactions | 3.22e-04 | 67 | 278 | 6 | int:SMAP1 | |
| Cytoband | 13q21.1 | 1.14e-08 | 13 | 287 | 5 | 13q21.1 | |
| Cytoband | 5q13 | 3.41e-04 | 22 | 287 | 3 | 5q13 | |
| Cytoband | 15q15.3 | 5.02e-04 | 25 | 287 | 3 | 15q15.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | AKAP8 MYO9B ABCA7 MIER2 SAMD1 C19orf67 UBXN6 MUC16 ARHGEF18 ANO8 MRPL4 ANGPTL4 MAST1 ARHGAP45 | 5.61e-04 | 797 | 287 | 14 | chr19p13 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | OBSCN ARHGEF17 FGD5 PREX1 RASGRF2 KALRN ARHGEF18 ARHGEF15 TIAM1 ARHGEF10 | 2.70e-09 | 66 | 200 | 10 | 722 |
| GeneFamily | PDZ domain containing | PTPN4 TJP2 PREX1 ARHGAP21 LNX2 TIAM1 MAST1 SCRIB SNTA1 AHNAK2 | 7.53e-06 | 152 | 200 | 10 | 1220 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | SPTB PHLDB1 FGD5 PREX1 ARHGAP21 RASAL1 RASGRF2 TRIOBP ARHGEF18 TIAM1 PSD4 | 1.91e-05 | 206 | 200 | 11 | 682 |
| GeneFamily | Fibronectin type III domain containing | 7.41e-05 | 160 | 200 | 9 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.77e-05 | 161 | 200 | 9 | 593 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 8.09e-04 | 17 | 200 | 3 | 486 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | MAP1B PDGFRB CHD3 TACC1 MAP4K4 COL1A1 RASGRF2 ZSWIM5 LAMA4 MTBP RERE | 1.36e-06 | 162 | 278 | 11 | M45037 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | GBF1 KMT2B MYO9B TMEM94 BIRC6 ZBTB37 HERC1 MAP4K4 POLE CREBBP PELP1 | 3.80e-06 | 180 | 278 | 11 | M8239 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | NES ZNF155 MAP1B PDGFRB OBSCN ARHGEF17 HECW2 FGD5 DMD COL1A1 SGIP1 LAMA4 ARHGEF15 IGDCC4 LIFR COL18A1 CSF1 SMARCA1 | 8.66e-06 | 505 | 278 | 18 | M39167 |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | FXYD5 IRF7 TTLL12 ZBP1 SGO2 MAP4K4 ARHGAP21 ARHGEF18 RNF213 CEP192 TIAM1 | 1.04e-05 | 200 | 278 | 11 | M7143 |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP | NCOA3 LZTR1 FXYD5 TFPT KATNIP GOLGB1 MAGED1 PIKFYVE SCRIB ARHGAP45 CUX1 | 1.04e-05 | 200 | 278 | 11 | M6623 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | BDP1 ANKIB1 NHS BICC1 PRUNE2 RNF213 AKAP12 COL18A1 RERE CUX1 | 1.98e-05 | 176 | 278 | 10 | M39223 |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | MAP1B PDGFRB FXYD5 PTEN FBLN2 PTPRC TACC1 MAP4K4 BICC1 COL1A1 IFFO1 LAMA4 SLC7A7 AHNAK2 | 2.68e-05 | 352 | 278 | 14 | M17471 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.24e-05 | 35 | 278 | 5 | MM17054 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_UP | 3.44e-05 | 58 | 278 | 6 | M2575 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_UP | 3.79e-05 | 59 | 278 | 6 | MM960 | |
| Coexpression | PGF_UP.V1_DN | MAP1A SPTB GPR182 OBSCN SRCAP ARC POU2F3 COL18A1 MAST1 ZNF646 | 3.81e-05 | 190 | 278 | 10 | M2673 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 4.35e-05 | 155 | 278 | 9 | M39246 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN | 5.88e-05 | 200 | 278 | 10 | M5977 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP | RIN3 FRS3 MAP4K4 PRRC2A BICC1 MUC16 ZBTB7B ARHGAP45 AHNAK2 ZNF646 | 5.88e-05 | 200 | 278 | 10 | M7437 |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | CHD1 CCDC88B BNIP2 PTPRC FBXW5 PREX1 TRIOBP ARHGAP45 PSD4 ZNF646 | 5.88e-05 | 200 | 278 | 10 | M5055 |
| Coexpression | GSE6875_WT_VS_FOXP3_KO_TREG_UP | NCOA3 ABCA7 HECW2 SDC1 ARHGEF18 POLE4 ZBTB7B AKAP12 MAST1 TNKS1BP1 | 5.88e-05 | 200 | 278 | 10 | M6803 |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 6.75e-05 | 164 | 278 | 9 | M5653 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | MYO9B CUL9 SRCAP ABCA7 EHMT2 ZBTB5 PRRC2A SMG5 ZBTB7B PPM1G SETD5 AGRN ZNF646 | 7.29e-05 | 338 | 278 | 13 | M17094 |
| Coexpression | ENK_UV_RESPONSE_EPIDERMIS_UP | FXYD5 IRF7 BTN3A3 EHMT2 TJP2 MAP4K4 HYOU1 POLE TRIOBP CBX4 CSF1 ANGPTL4 | 8.39e-05 | 296 | 278 | 12 | M19848 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NCOA3 CHD1 POGZ BRD8 TMEM131L ADGRL2 TAF11 ICE1 CREBBP PIKFYVE MTIF2 AKR1C3 | 9.52e-05 | 300 | 278 | 12 | M8702 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | PDGFRB PTEN ARHGEF17 DMD LAMA4 AKAP12 SLC6A12 COL18A1 ANGPTL4 TNKS1BP1 AGRN EPB41L1 | 1.05e-04 | 303 | 278 | 12 | M39040 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | ZNF142 LZTR1 HK3 MYO9B FRS3 FXYD5 IRF7 ATG2A KRBA1 CLN3 ASCC2 TMEM131L KATNIP IFFO1 SMG5 CEP192 CREBBP PARP10 SCAP PLCH2 ZSCAN18 ZFHX3 CUX1 | 1.09e-04 | 905 | 278 | 23 | M40865 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.11e-04 | 137 | 278 | 8 | M39241 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 1.12e-04 | 45 | 278 | 5 | M1605 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 1.24e-04 | 46 | 278 | 5 | MM1187 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.34e-04 | 221 | 278 | 10 | M39222 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 MAP1B SPEG FRS3 CHD3 PTEN RNF157 AMER2 SCN9A KBTBD11 ANKIB1 NAV1 HERC1 ANK2 NTRK3 MUC19 CBX4 SLC4A3 PTPRT ANO8 MAST1 ZFHX3 DCLK1 EPB41L1 FRMD3 AHNAK2 | 1.37e-04 | 1106 | 278 | 26 | M39071 |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | MAP1B PDGFRB SPEG NHS DMD COL1A1 PRUNE2 SGIP1 GARNL3 KALRN NTRK3 LAMA4 AKAP12 ZFHX3 | 1.11e-11 | 180 | 283 | 14 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB SPEG PTEN ARHGEF17 TMEM131L DMD COL1A1 SGIP1 KALRN NTRK3 ZFHX3 DCLK1 | 4.43e-10 | 196 | 283 | 13 | b8759e6231e0254797d6c30930407b79440c57bb |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | MAP1B PDGFRB NHS TACC1 DMD PRUNE2 SGIP1 KALRN NTRK3 AKAP12 COL18A1 ZFHX3 | 5.50e-10 | 161 | 283 | 12 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | PDGFRB PHLDB1 FBLN2 NAV1 BICC1 COL1A1 ROR2 LAMA4 AKAP12 IGDCC4 TNXB DCLK1 | 2.70e-09 | 185 | 283 | 12 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | NES PHLDB1 HECW2 NAV1 FGD5 ADGRL2 PREX1 KALRN ARHGEF15 LIFR ARHGEF10 BTNL9 | 2.87e-09 | 186 | 283 | 12 | c6075fe84226b370c5139066793844ad33ae2db1 |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | NES MAP1B PDGFRB SPTB OBSCN ARHGEF17 PHLDB1 TACC1 ADGRL2 SGIP1 LAMA4 COL18A1 | 3.05e-09 | 187 | 283 | 12 | 62759efb660179402fb574ce5701c89a2e17bcfe |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB SPEG ARHGEF17 ACAN TMEM131L DMD COL1A1 KALRN NTRK3 ROR2 DCLK1 | 3.65e-09 | 190 | 283 | 12 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | PDGFRB FBLN2 NAV1 BICC1 COL1A1 ANK2 ROR2 LAMA4 AKAP12 IGDCC4 TNXB DCLK1 | 4.11e-09 | 192 | 283 | 12 | d21f0f577156f17c899b08871046a26b88aea011 |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NES PHLDB1 HECW2 NAV1 FGD5 ADGRL2 PREX1 KALRN ARHGEF15 LIFR ARHGEF10 BTNL9 | 4.35e-09 | 193 | 283 | 12 | f582e939e3e08a8a3f71deec78c33715be8faa51 |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | ADGRL2 BICC1 COL1A1 SGIP1 KALRN KIF26B ROR2 LAMA4 AKAP12 LIFR COL18A1 SMARCA1 | 6.15e-09 | 199 | 283 | 12 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B PDGFRB SPEG SPTB ARHGEF17 ACAN ARC DMD NTRK3 AKAP12 COL18A1 ZFHX3 | 6.15e-09 | 199 | 283 | 12 | c2903b1a4b91e94bbdaa909bacefe901255cf248 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB PHLDB1 FBLN2 NAV1 BICC1 COL1A1 ANK2 ROR2 LAMA4 AKAP12 TNXB DCLK1 | 6.50e-09 | 200 | 283 | 12 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | NES MAP1A MAP1B PDGFRB ARHGEF17 ACAN TMEM131L DMD MYO18B COL1A1 NTRK3 ZFHX3 | 6.50e-09 | 200 | 283 | 12 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB FBLN2 NAV1 TACC1 BICC1 COL1A1 SGIP1 ANK2 LAMA4 AKAP12 TNXB DCLK1 | 6.50e-09 | 200 | 283 | 12 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | MAP1B PDGFRB PHLDB1 FBLN2 BICC1 COL1A1 ANK2 LAMA4 AKAP12 COL18A1 TNXB DCLK1 | 6.50e-09 | 200 | 283 | 12 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B PDGFRB FBLN2 BICC1 COL1A1 SGIP1 NTRK3 ROR2 LAMA4 COL18A1 TNXB DCLK1 | 6.50e-09 | 200 | 283 | 12 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B PDGFRB SPEG NHS DMD PRUNE2 SGIP1 KALRN NTRK3 LAMA4 AKAP12 COL18A1 | 6.50e-09 | 200 | 283 | 12 | a66449b22b39dd6987fc2c3ed160d24564234ced |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | MAP1B PDGFRB PHLDB1 FBLN2 BICC1 COL1A1 ANK2 LAMA4 AKAP12 COL18A1 TNXB DCLK1 | 6.50e-09 | 200 | 283 | 12 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | MAP1B PDGFRB PHLDB1 FBLN2 BICC1 COL1A1 ANK2 LAMA4 AKAP12 COL18A1 TNXB DCLK1 | 6.50e-09 | 200 | 283 | 12 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB FBLN2 NAV1 BICC1 COL1A1 ANK2 ROR2 LAMA4 AKAP12 IGDCC4 TNXB DCLK1 | 6.50e-09 | 200 | 283 | 12 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1A MAP1B PDGFRB FBLN2 BICC1 COL1A1 ANK2 LAMA4 AKAP12 CSF1 TNXB DCLK1 | 6.50e-09 | 200 | 283 | 12 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NES PDGFRB PCDH12 HECW2 FGD5 SGIP1 LAMA4 ARHGEF15 CSF1 TMEM132E FRMD3 | 1.45e-08 | 172 | 283 | 11 | 073a503dc922e3e3ac3528e249b0f8b74402110b |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | NES MAP1A MAP1B PDGFRB SPTB ACAN COL1A1 SGIP1 GARNL3 NTRK3 COL18A1 | 2.75e-08 | 183 | 283 | 11 | 4617b18da8d699a44e4c47980197b1e7eb951470 |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | MAP1B PDGFRB SPTB OBSCN PTEN ARHGEF17 PHLDB1 TACC1 ADGRL2 SGIP1 COL18A1 | 2.75e-08 | 183 | 283 | 11 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | NES MAP1B PDGFRB SPEG ACAN DMD COL1A1 KALRN NTRK3 MACROD2 ZFHX3 | 3.24e-08 | 186 | 283 | 11 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | PDGFRB OBSCN PTEN ARHGEF17 PHLDB1 TACC1 ADGRL2 SGIP1 KALRN NTRK3 ZFHX3 | 3.43e-08 | 187 | 283 | 11 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | MAP1B SPEG NHS DMD BICC1 PRUNE2 KALRN KIF26B NTRK3 ROR2 AKAP12 | 3.43e-08 | 187 | 283 | 11 | 464a0c3b92b778911b5f9cd73642e09e3472063a |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | PHLDB1 HECW2 NAV1 FGD5 ADGRL2 PREX1 KALRN ARHGEF15 LIFR ARHGEF10 BTNL9 | 3.62e-08 | 188 | 283 | 11 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB SPEG ARHGEF17 ACAN TMEM131L DMD MYO18B ALPP NTRK3 ZFHX3 | 3.82e-08 | 189 | 283 | 11 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB SPEG ARHGEF17 ACAN TMEM131L DMD MYO18B ALPP NTRK3 ZFHX3 | 3.82e-08 | 189 | 283 | 11 | 2cfb4d12f75678d1619f4743838a0e954bd57761 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | FBLN2 ARL13B NHS BICC1 COL1A1 ANK2 ROR2 AKAP12 LIFR TNXB DCLK1 | 4.04e-08 | 190 | 283 | 11 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NES MAP1B PDGFRB OBSCN PTEN ARHGEF17 PHLDB1 TACC1 SGIP1 LAMA4 COL18A1 | 4.04e-08 | 190 | 283 | 11 | 4eb92aef1ee868f4537483d19014d947b7684612 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NES MAP1B PDGFRB OBSCN PTEN ARHGEF17 PHLDB1 TACC1 SGIP1 LAMA4 COL18A1 | 4.04e-08 | 190 | 283 | 11 | 7be4341e2909101d756f14031c21e705eb45e69a |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | MAP1B PDGFRB SPEG SPTB ARHGEF17 ACAN NHS DMD KALRN NTRK3 COL18A1 | 4.26e-08 | 191 | 283 | 11 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB SPEG ACAN TACC1 DMD COL1A1 SGIP1 KALRN NTRK3 ZFHX3 | 4.26e-08 | 191 | 283 | 11 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | FBLN2 BICC1 COL1A1 ANK2 NTRK3 ROR2 LAMA4 AKAP12 IGDCC4 TNXB DCLK1 | 4.49e-08 | 192 | 283 | 11 | a769158c49d2b208c4224d85e7ae68c85cc372ed |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | NES HECW2 FGD5 ADGRL2 MARCHF4 RASGRF2 KALRN ARHGEF15 AKAP12 ARHGEF10 BTNL9 | 4.74e-08 | 193 | 283 | 11 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | PDGFRB FBLN2 BICC1 COL1A1 ANK2 ROR2 LAMA4 AKAP12 IGDCC4 TNXB DCLK1 | 4.74e-08 | 193 | 283 | 11 | 9ab47b360bee1d4f1092c2269e58acebe9584021 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MAP1B PDGFRB NHS BICC1 COL1A1 SGIP1 RASGRF2 KIF26B NTRK3 ROR2 LAMA4 | 4.74e-08 | 193 | 283 | 11 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MAP1B PDGFRB OBSCN ARHGEF17 BICC1 COL1A1 SGIP1 KIF26B NTRK3 LAMA4 COL18A1 | 5.00e-08 | 194 | 283 | 11 | 2d66091097e106c7bee22e5281f50724700bdf8d |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | NES MAP1A MAP1B DACT2 PPP1R1B SCN9A DMD CHPF GOLGB1 PRUNE2 AKAP12 | 5.00e-08 | 194 | 283 | 11 | 8985095f291c1b54e45f4edece49aa26e8c8b732 |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | NES MAP1A PDGFRB CHGB PCDH12 FBLN2 BICC1 COL1A1 LAMA4 DCLK1 MYBPC2 | 5.00e-08 | 194 | 283 | 11 | 55b97095a7a17a312c616703d291738a0f806339 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | PDGFRB PHLDB1 BICC1 COL1A1 ANK2 NTRK3 ROR2 AKAP12 ANGPTL4 TNXB DCLK1 | 5.27e-08 | 195 | 283 | 11 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | NES MAP1B PDGFRB SPEG ARHGEF17 ACAN DMD PRUNE2 NTRK3 COL18A1 ZFHX3 | 5.27e-08 | 195 | 283 | 11 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | MAP1B PDGFRB PTEN ARHGEF17 ACAN TACC1 DMD SGIP1 NTRK3 COL18A1 ZFHX3 | 5.55e-08 | 196 | 283 | 11 | 754a3613340932563cd8424d775e18b93c3a1aaa |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | NES PCDH12 HECW2 FGD5 ADGRL2 LAMA4 AKAP12 LIFR FUT11 BTNL9 TNXB | 5.55e-08 | 196 | 283 | 11 | 14dd6956ef420b660be0baf52a66960e57d75d16 |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | RIN3 PCDH12 NAV1 TACC1 FGD5 ADGRL2 RASGRF2 KALRN LAMA4 ARHGEF15 BTNL9 | 5.55e-08 | 196 | 283 | 11 | b71b197cb92117dd9efaa13de000841901cc4ca8 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B PDGFRB SPEG NHS PRUNE2 SGIP1 KALRN NTRK3 LAMA4 AKAP12 COL18A1 | 5.84e-08 | 197 | 283 | 11 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B PDGFRB SPEG DMD PRUNE2 SGIP1 GARNL3 KALRN NTRK3 LAMA4 AKAP12 | 5.84e-08 | 197 | 283 | 11 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | HECW2 NAV1 TACC1 FGD5 PREX1 RASGRF2 KALRN ARHGEF15 LIFR BTNL9 TNXB | 5.84e-08 | 197 | 283 | 11 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB PTEN TMEM131L DMD COL1A1 SGIP1 KALRN NTRK3 AKAP12 DCLK1 | 6.15e-08 | 198 | 283 | 11 | 79576525a10ed3e3a9d1608077cd16ecda23376f |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | PDGFRB FBLN2 BICC1 COL1A1 SGIP1 ANK2 ROR2 LAMA4 AKAP12 TNXB DCLK1 | 6.15e-08 | 198 | 283 | 11 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | PDGFRB NHS BICC1 COL1A1 SGIP1 KALRN ROR2 LAMA4 AKAP12 LIFR DCLK1 | 6.15e-08 | 198 | 283 | 11 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B PDGFRB SPEG DMD PRUNE2 GARNL3 KALRN NTRK3 LAMA4 AKAP12 COL18A1 | 6.15e-08 | 198 | 283 | 11 | bd42c03e384e64f61b02618cf1a5440033bb04b2 |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NES PCDH12 PHLDB1 HECW2 ARC ADGRL2 MIER2 KALRN CSF1 ARHGEF10 BTNL9 | 6.48e-08 | 199 | 283 | 11 | 9364199c5b4540ce2e14341fd9d504b695f8249d |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | MAP1B PDGFRB FBLN2 BICC1 COL1A1 ANK2 LAMA4 AKAP12 AKR1C3 TNXB DCLK1 | 6.48e-08 | 199 | 283 | 11 | 66545eb7f65e450b742628fd431956e13330a0d3 |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | MAP1B PDGFRB FBLN2 BICC1 COL1A1 ANK2 LAMA4 AKAP12 AKR1C3 TNXB DCLK1 | 6.48e-08 | 199 | 283 | 11 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B PDGFRB SPEG ARHGEF17 ACAN COL1A1 NTRK3 LAMA4 AKAP12 COL18A1 ANGPTL4 | 6.48e-08 | 199 | 283 | 11 | 20f760d92c351a1dac4cc0a424c443ea03a179fe |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B PDGFRB SPEG SPTB ARHGEF17 ACAN COL1A1 NTRK3 LAMA4 AKAP12 COL18A1 | 6.48e-08 | 199 | 283 | 11 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | PDGFRB PHLDB1 FBLN2 ARC COL1A1 ANK2 LAMA4 AKAP12 ANGPTL4 TNXB DCLK1 | 6.82e-08 | 200 | 283 | 11 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B PDGFRB BICC1 COL1A1 SGIP1 ANK2 ROR2 LAMA4 AKAP12 TNXB DCLK1 | 6.82e-08 | 200 | 283 | 11 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | NES MAP1B PDGFRB ARHGEF17 AMER2 ACAN DMD MYO18B COL1A1 NTRK3 ZFHX3 | 6.82e-08 | 200 | 283 | 11 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB FBLN2 NAV1 TACC1 BICC1 COL1A1 ANK2 LAMA4 AKAP12 TNXB DCLK1 | 6.82e-08 | 200 | 283 | 11 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MAP1A MAP1B PDGFRB ARHGEF17 ACAN TMEM131L DMD COL1A1 NTRK3 COL18A1 ZFHX3 | 6.82e-08 | 200 | 283 | 11 | a3a1e35934d676c39f917652e50c502cb2f613c1 |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NES MAP1B PDGFRB ARHGEF17 PHLDB1 TACC1 SGIP1 KALRN LAMA4 COL18A1 FRMD3 | 6.82e-08 | 200 | 283 | 11 | 9d3ae9ea47b1017adb63aa02d10e98193d478458 |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.21e-08 | 160 | 283 | 10 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | MAP1B PDGFRB OBSCN PTEN ARHGEF17 ADGRL2 SGIP1 NTRK3 LAMA4 COL18A1 | 1.53e-07 | 171 | 283 | 10 | 080003f698f867935c2bfc55d241d3650f45a0ab |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | MAP1B ZNF391 GPR182 PCDH12 KIF26B LAMA4 ARHGEF15 AKAP12 TNXB DCLK1 | 1.62e-07 | 172 | 283 | 10 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-07 | 173 | 283 | 10 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.60e-07 | 181 | 283 | 10 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | MAP1B PDGFRB PHLDB1 FBLN2 NAV1 BICC1 COL1A1 IGDCC4 TNXB DCLK1 | 3.02e-07 | 184 | 283 | 10 | 2b7e6f91e11c228f0521e099886867d9e998e78d |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | RIN3 GPR182 CCDC88B FBLN2 COL1A1 ALPK1 PARP10 SLC6A12 SLC6A13 | 3.27e-07 | 142 | 283 | 9 | 3557084150670fd2e2634fc674f228ab85181b59 |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | RIN3 GPR182 CCDC88B FBLN2 COL1A1 ALPK1 PARP10 SLC6A12 SLC6A13 | 3.27e-07 | 142 | 283 | 9 | 6a656d28c9f5dfb03a3a2d908cf2edbe0a5b1206 |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | RIN3 GPR182 CCDC88B FBLN2 COL1A1 ALPK1 PARP10 SLC6A12 SLC6A13 | 3.27e-07 | 142 | 283 | 9 | 671ba8869db7a6dc69fd1caf0e561f15a312b170 |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | RIN3 GPR182 CCDC88B FBLN2 COL1A1 ALPK1 PARP10 SLC6A12 SLC6A13 | 3.27e-07 | 142 | 283 | 9 | a3d1f4b570b75402171e38c5a7c88e2896520c8f |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | FBLN2 SYCE1 COL1A1 MIER2 CEP192 AKAP12 IGDCC4 BSCL2 TNXB AHNAK2 | 3.34e-07 | 186 | 283 | 10 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NES MAP1B PDGFRB OBSCN PTEN ARHGEF17 TACC1 DMD SGIP1 COL18A1 | 3.34e-07 | 186 | 283 | 10 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | FBLN2 SYCE1 COL1A1 MIER2 CEP192 AKAP12 IGDCC4 BSCL2 TNXB AHNAK2 | 3.34e-07 | 186 | 283 | 10 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.51e-07 | 187 | 283 | 10 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.69e-07 | 188 | 283 | 10 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | NES OBSCN PHLDB1 HECW2 FGD5 ADGRL2 PREX1 KALRN ARHGEF15 BTNL9 | 3.69e-07 | 188 | 283 | 10 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-07 | 189 | 283 | 10 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | LAM-Endothelial-VasEndo-1|LAM / Condition, Lineage and Cell class | NES PCDH12 PHLDB1 HECW2 ARC ADGRL2 MIER2 ARHGEF15 ARHGEF10 BTNL9 | 3.87e-07 | 189 | 283 | 10 | 454e64b1ee93edebbc1576fbf7c3a6db332fa927 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB SPEG ARHGEF17 ACAN TMEM131L DMD NTRK3 ZFHX3 DCLK1 | 3.87e-07 | 189 | 283 | 10 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB SPEG ARHGEF17 ACAN TMEM131L DMD NTRK3 ZFHX3 DCLK1 | 3.87e-07 | 189 | 283 | 10 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-07 | 190 | 283 | 10 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.06e-07 | 190 | 283 | 10 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-07 | 190 | 283 | 10 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-07 | 190 | 283 | 10 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | MAP1B PDGFRB PTEN ARHGEF17 NHS TACC1 RASGRF2 ZFHX3 BTNL9 FRMD3 | 4.06e-07 | 190 | 283 | 10 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDGFRB SPEG ARHGEF17 ACAN DMD COL1A1 PRUNE2 ANK2 NTRK3 ZFHX3 | 4.26e-07 | 191 | 283 | 10 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB PTEN ARHGEF17 TMEM131L DMD COL1A1 SGIP1 KALRN NTRK3 | 4.26e-07 | 191 | 283 | 10 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB PTEN ARHGEF17 TMEM131L DMD COL1A1 SGIP1 KALRN NTRK3 | 4.26e-07 | 191 | 283 | 10 | cd854b9c426924fdc84bf7f411f6dea447143e79 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | FBLN2 ARHGAP21 BICC1 COL1A1 ANK2 NTRK3 AKAP12 IGDCC4 TNXB DCLK1 | 4.47e-07 | 192 | 283 | 10 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | NES PCDH12 PHLDB1 HECW2 FGD5 ADGRL2 PREX1 KALRN ARHGEF15 BTNL9 | 4.47e-07 | 192 | 283 | 10 | 1e156bab5ecf64627890d2de9b27603d9a01f28d |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | PDGFRB FBLN2 BICC1 COL1A1 ANK2 ROR2 LAMA4 AKAP12 IGDCC4 DCLK1 | 4.47e-07 | 192 | 283 | 10 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-07 | 192 | 283 | 10 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | NES MAP1B PDGFRB SPEG ACAN COL1A1 NTRK3 LAMA4 AKAP12 COL18A1 | 4.47e-07 | 192 | 283 | 10 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDGFRB C11orf24 FBLN2 SDC1 COL1A1 MAGED1 COL18A1 CSF1 TNXB DCLK1 | 4.69e-07 | 193 | 283 | 10 | 316ebdf15f75d88c348f909b643fcd315364ca84 |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | MAP1B PDGFRB SPEG ARHGEF17 ACAN DMD PRUNE2 SGIP1 NTRK3 COL18A1 | 4.92e-07 | 194 | 283 | 10 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 |
| Disease | obsolete aging, cognition | 2.10e-07 | 15 | 281 | 5 | EFO_0003925, GO_0007568 | |
| Disease | Colorectal Carcinoma | ERCC6 HK3 ZNF155 MAP1B OBSCN CHD1 PTEN AMER2 FBLN2 DMD ANK2 RASGRF2 KALRN ZSCAN5A POLE PTPRT AKAP12 LIFR TIAM1 DCLK1 CUX1 | 4.45e-06 | 702 | 281 | 21 | C0009402 |
| Disease | prostate cancer (implicated_via_orthology) | 1.44e-05 | 33 | 281 | 5 | DOID:10283 (implicated_via_orthology) | |
| Disease | JT interval | GBF1 NACA OBSCN KCNH2 KBTBD11 CLUH SGIP1 CREBBP SLC4A3 SPDYE3 CUX1 | 2.87e-05 | 248 | 281 | 11 | EFO_0007885 |
| Disease | long QT syndrome (is_implicated_in) | 2.91e-05 | 7 | 281 | 3 | DOID:2843 (is_implicated_in) | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 3.98e-05 | 66 | 281 | 6 | EFO_0007708 | |
| Disease | triacylglycerol 58:9 measurement | 5.14e-05 | 22 | 281 | 4 | EFO_0010443 | |
| Disease | breast cancer (is_marker_for) | 7.56e-05 | 185 | 281 | 9 | DOID:1612 (is_marker_for) | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 9.04e-05 | 2 | 281 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Intellectual Disability | ZNF142 MAP1B PDGFRB TMEM94 CHD3 POGZ PCDH12 PTEN ARL13B CUX2 COL18A1 ZNF335 LNPK EPB41L1 | 1.11e-04 | 447 | 281 | 14 | C3714756 |
| Disease | mosaic loss of chromosome Y measurement | 1.18e-04 | 80 | 281 | 6 | EFO_0007783 | |
| Disease | Sezary Syndrome | 1.19e-04 | 27 | 281 | 4 | C0036920 | |
| Disease | platelet component distribution width | RIN3 MYO9B FXYD5 PWWP2A BRD8 PTPRC CLN3 TMEM131L HERC1 PRRC2A PREX1 PRUNE2 LNX2 KALRN ZNF629 ARHGEF15 COL18A1 TNXB CUX1 | 1.29e-04 | 755 | 281 | 19 | EFO_0007984 |
| Disease | rheumatoid arthritis | RIN3 KMT2B CCDC88B PTPRC CASTOR1 TELO2 PREX1 PHRF1 ZNF629 REL ALPK1 ANO8 SPDYE3 TTC33 | 1.56e-04 | 462 | 281 | 14 | EFO_0000685 |
| Disease | short QT syndrome (implicated_via_orthology) | 2.69e-04 | 3 | 281 | 2 | DOID:0050793 (implicated_via_orthology) | |
| Disease | anemia (implicated_via_orthology) | 3.57e-04 | 15 | 281 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | AKAP8 MYO9B RPS6KA1 SPTB PTEN ABCA7 KRBA1 PTPRC HECW2 ASCC2 PREX1 ARHGAP21 GOLGB1 CUX2 KALRN ZDHHC5 SMG5 ARHGEF15 SLC4A2 IGDCC4 RP1L1 MAST1 ZNF654 | 4.11e-04 | 1105 | 281 | 23 | EFO_0004528 |
| Disease | Romano-Ward Syndrome | 4.37e-04 | 16 | 281 | 3 | C0035828 | |
| Disease | Malignant neoplasm of endometrium | 6.27e-04 | 18 | 281 | 3 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 6.27e-04 | 18 | 281 | 3 | C0346191 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.59e-04 | 152 | 281 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | NCOA3 ERCC6 HK3 AKAP8 OBSCN PTEN PTPRC NHS FGD5 DMD PRRC2A GOLGB1 ANK2 RASGRF2 KALRN ZSWIM5 SLC7A7 AKAP12 CSF1 ANGPTL4 CUX1 ZNF646 | 6.77e-04 | 1074 | 281 | 22 | C0006142 |
| Disease | Calcinosis | 6.78e-04 | 42 | 281 | 4 | C0006663 | |
| Disease | Microcalcification | 6.78e-04 | 42 | 281 | 4 | C0521174 | |
| Disease | Tumoral calcinosis | 6.78e-04 | 42 | 281 | 4 | C0263628 | |
| Disease | immunoglobulin isotype switching measurement | 8.10e-04 | 44 | 281 | 4 | EFO_0010128 | |
| Disease | Gastric Adenocarcinoma | 8.82e-04 | 45 | 281 | 4 | C0278701 | |
| Disease | Cardiac Arrest | 8.87e-04 | 5 | 281 | 2 | C0018790 | |
| Disease | Joubert syndrome 1 | 1.00e-03 | 21 | 281 | 3 | C4551568 | |
| Disease | Carcinoma of lung | 1.31e-03 | 23 | 281 | 3 | C0684249 | |
| Disease | brain disease (implicated_via_orthology) | 1.32e-03 | 6 | 281 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | childhood onset asthma, age at onset, environmental tobacco smoke exposure measurement | 1.32e-03 | 6 | 281 | 2 | EFO_0004847, EFO_0008361, MONDO_0005405 | |
| Disease | Leukemia, Myelocytic, Acute | 1.40e-03 | 173 | 281 | 7 | C0023467 | |
| Disease | Dystonia | 1.40e-03 | 86 | 281 | 5 | C0013421 | |
| Disease | Malignant Neoplasms | 1.45e-03 | 128 | 281 | 6 | C0006826 | |
| Disease | Global developmental delay | 1.77e-03 | 133 | 281 | 6 | C0557874 | |
| Disease | Melanoma, B16 | 1.84e-03 | 7 | 281 | 2 | C0004565 | |
| Disease | arabitol measurement | 1.84e-03 | 7 | 281 | 2 | EFO_0800148 | |
| Disease | Melanoma, Harding-Passey | 1.84e-03 | 7 | 281 | 2 | C0018598 | |
| Disease | Melanoma, Cloudman S91 | 1.84e-03 | 7 | 281 | 2 | C0009075 | |
| Disease | Melanoma, Experimental | 1.84e-03 | 7 | 281 | 2 | C0025205 | |
| Disease | QT interval | GBF1 KCNH2 TMEM131L CLUH ARHGAP21 SGIP1 RASGRF2 ICE1 CREBBP SLC4A3 SCAP ZFHX3 CUX1 | 1.98e-03 | 534 | 281 | 13 | EFO_0004682 |
| Disease | Neurodevelopmental Disorders | 1.99e-03 | 93 | 281 | 5 | C1535926 | |
| Disease | platelet crit | RIN3 MAP1A MYO9B GPATCH8 PTEN TTLL12 PWWP2A KRBA1 PTPRC CLN3 FBXW5 TMEM131L PREX1 KALRN ZC3HC1 CSF1 FMN2 RERE CUX1 | 2.09e-03 | 952 | 281 | 19 | EFO_0007985 |
| Disease | Tinnitus, wellbeing measurement | 2.28e-03 | 96 | 281 | 5 | EFO_0007869, HP_0000360 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 2.44e-03 | 8 | 281 | 2 | EFO_0008309 | |
| Disease | Ventricular Fibrillation | 2.44e-03 | 8 | 281 | 2 | C0042510 | |
| Disease | response to selective serotonin reuptake inhibitor, body mass index | 2.44e-03 | 8 | 281 | 2 | EFO_0004340, EFO_0005658 | |
| Disease | endometrial cancer (implicated_via_orthology) | 2.44e-03 | 8 | 281 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | corpus callosum volume measurement | 2.73e-03 | 100 | 281 | 5 | EFO_0010299 | |
| Disease | cardiac arrhythmia | 2.87e-03 | 30 | 281 | 3 | EFO_0004269 | |
| Disease | hypertension | 2.88e-03 | 307 | 281 | 9 | EFO_0000537 | |
| Disease | Neuronal ceroid lipofuscinosis | 3.11e-03 | 9 | 281 | 2 | cv:C0027877 | |
| Disease | Prostatic Cancer, Castration-Resistant | 3.11e-03 | 9 | 281 | 2 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 3.11e-03 | 9 | 281 | 2 | C3658267 | |
| Disease | anemia (phenotype), response to ribavirin | 3.11e-03 | 9 | 281 | 2 | EFO_0004272, GO_1901559 | |
| Disease | Osteitis Deformans | 3.11e-03 | 9 | 281 | 2 | C0029401 | |
| Disease | Malignant tumor of prostate | 3.11e-03 | 9 | 281 | 2 | cv:C0376358 | |
| Disease | neutrophil count | NES RIN3 ZNF391 POGZ PTEN ABCA7 TTLL12 PTPRC TELO2 ADGRL2 MAP4K4 PREX1 PRUNE2 CUX2 SGIP1 ZC3HC1 ZBTB7B CREBBP AKAP12 MRPL4 RP1L1 RERE ARHGAP45 TNXB | 3.53e-03 | 1382 | 281 | 24 | EFO_0004833 |
| Disease | alopecia areata (is_marker_for) | 3.87e-03 | 10 | 281 | 2 | DOID:986 (is_marker_for) | |
| Disease | prostate cancer (is_marker_for) | 3.91e-03 | 156 | 281 | 6 | DOID:10283 (is_marker_for) | |
| Disease | Benign Neoplasm | 4.07e-03 | 68 | 281 | 4 | C0086692 | |
| Disease | Neoplasms | 4.07e-03 | 68 | 281 | 4 | C0027651 | |
| Disease | Macrocephaly | 4.70e-03 | 11 | 281 | 2 | C0221355 | |
| Disease | Shortened QT interval | 4.70e-03 | 11 | 281 | 2 | C0151879 | |
| Disease | Long QT Syndrome | 4.70e-03 | 11 | 281 | 2 | C0023976 | |
| Disease | Nephrosclerosis | 4.70e-03 | 11 | 281 | 2 | C0027719 | |
| Disease | Prostatic Intraepithelial Neoplasias | 4.70e-03 | 11 | 281 | 2 | C0282612 | |
| Disease | Congenital long QT syndrome | 4.70e-03 | 11 | 281 | 2 | cv:C1141890 | |
| Disease | kidney cancer (implicated_via_orthology) | 4.70e-03 | 11 | 281 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | immature platelet fraction | 4.77e-03 | 114 | 281 | 5 | EFO_0009187 | |
| Disease | Endometrial Carcinoma | 4.99e-03 | 72 | 281 | 4 | C0476089 | |
| Disease | eye morphology measurement | 5.07e-03 | 218 | 281 | 7 | EFO_0007858 | |
| Disease | seasonality measurement | 5.60e-03 | 12 | 281 | 2 | EFO_0006876 | |
| Disease | Dental enamel hypoplasia | 5.60e-03 | 12 | 281 | 2 | EFO_1001304 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 5.60e-03 | 12 | 281 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Long QT syndrome | 5.60e-03 | 12 | 281 | 2 | cv:C0023976 | |
| Disease | complement factor H-related protein 3 measurement | 5.75e-03 | 169 | 281 | 6 | EFO_0600056 | |
| Disease | interleukin 18 measurement | 6.04e-03 | 76 | 281 | 4 | EFO_0004581 | |
| Disease | Disproportionate short stature | 6.32e-03 | 77 | 281 | 4 | C0878659 | |
| Disease | hematologic cancer (implicated_via_orthology) | 6.58e-03 | 13 | 281 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | renal sinus adipose tissue measurement | 6.58e-03 | 13 | 281 | 2 | EFO_0004864 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 6.58e-03 | 13 | 281 | 2 | C1846647 | |
| Disease | sphingomyelin 18:1 measurement | 6.58e-03 | 13 | 281 | 2 | EFO_0010394 | |
| Disease | basophil count | RIN3 CHD1 PTEN PTPRC CUX2 TRIOBP ZC3HC1 ARHGEF18 GMEB1 RERE TNXB | 6.97e-03 | 483 | 281 | 11 | EFO_0005090 |
| Disease | hip bone mineral density | 7.25e-03 | 126 | 281 | 5 | EFO_0007702 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 7.46e-03 | 42 | 281 | 3 | DOID:612 (is_implicated_in) | |
| Disease | acylcarnitine measurement | 7.49e-03 | 127 | 281 | 5 | EFO_0005059 | |
| Disease | ceramide measurement | 7.54e-03 | 235 | 281 | 7 | EFO_0010222 | |
| Disease | Nonsyndromic Deafness | 7.55e-03 | 81 | 281 | 4 | C3711374 | |
| Disease | revision of total hip arthroplasty | 7.63e-03 | 14 | 281 | 2 | EFO_0020973 | |
| Disease | cervical carcinoma | 8.16e-03 | 182 | 281 | 6 | EFO_0001061 | |
| Disease | basophil count, eosinophil count | 8.60e-03 | 241 | 281 | 7 | EFO_0004842, EFO_0005090 | |
| Disease | schizophrenia (biomarker_via_orthology) | 8.74e-03 | 15 | 281 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | mean arterial pressure | MYO9B SIK1 FGD5 POU2F3 PREX1 CUX2 SGIP1 RNF213 UTP25 ZFHX3 RERE | 8.78e-03 | 499 | 281 | 11 | EFO_0006340 |
| Disease | lung adenocarcinoma (is_marker_for) | 8.92e-03 | 85 | 281 | 4 | DOID:3910 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SAGLEQPTDPVARDG | 361 | O75410 | |
| GASPTGETPTIEEGE | 111 | P04920 | |
| DEDDSPGLPGRAAVT | 171 | P48751 | |
| SPDGPSDTESKELGV | 36 | Q96Q91 | |
| GELSSAPEAPGTQEG | 116 | O75150 | |
| ELVPSEEDFQGITPG | 581 | O75150 | |
| PVRGTGVPEENDSDT | 506 | Q6UXG8 | |
| TDVPTVDFGGAEPQE | 51 | A6H8Y1 | |
| AEPGPGEVRTAEDAS | 306 | Q8N7J2 | |
| EDGAGAETTPVAEPT | 91 | O15013 | |
| SDIPGSSEESPQVVE | 956 | Q6ZSZ5 | |
| EGRSTLGDAEASDPP | 291 | Q15018 | |
| QGTEGSTDLPLAPES | 81 | Q9BY76 | |
| GVKPDASDQEPEGLT | 4461 | Q9NR09 | |
| LTPGLANESGEPQAE | 536 | O00478 | |
| GPSEPSSVQLEEQEG | 651 | A6NC98 | |
| PSELLVGDGGSEESQ | 921 | Q9H0E9 | |
| GSSSLEGEPANPVDD | 1216 | Q9H0E9 | |
| DEGPTDTAEAGSDPQ | 606 | O43823 | |
| EVGGEPVPVTRDDSS | 146 | Q8WTX7 | |
| SLKPGEELSPTDENG | 121 | P42330 | |
| VSGEDPTQGADLSPD | 471 | Q02952 | |
| AGPTGANEDDSDVPA | 831 | Q02952 | |
| VEATEGPGSADTEEP | 1341 | P39880 | |
| EDGQPSPGVDTQIFE | 201 | Q7LC44 | |
| EEPNGEPNGVTVTAE | 421 | Q9H1I8 | |
| DGETPVLGESPSGTD | 1471 | O00468 | |
| RAPVQDTEATPGEGT | 11 | Q7RTS1 | |
| ESGEQGPETLAPASG | 6 | P0DPF6 | |
| TQAEDTEPDPGESKG | 1001 | Q92793 | |
| DEPSESTLDIPEGGS | 791 | Q9P2G1 | |
| PVKPVIGGSSSEDDA | 1286 | O95490 | |
| TPVGATPLIGDESEN | 81 | Q96KQ7 | |
| EDGIQTGDSPDEAPQ | 306 | O94989 | |
| DGTSGLAELDPEPTN | 241 | Q3SXY8 | |
| NPALVGSETAEPTEE | 31 | A0A0U1RR37 | |
| EPGSQTDVPAAGAAE | 156 | Q9UI46 | |
| GEEDLLSPPQDTSTG | 3641 | P11532 | |
| AEQRPEVPEGSASGE | 141 | Q96NY7 | |
| EQREGTSPAGPTLTE | 146 | O14529 | |
| QQLEGTDGPLVTDPE | 76 | Q96DB9 | |
| SPVPGSEDDLVAGAT | 26 | Q9H694 | |
| THENEPGPLTVGDEL | 1001 | O14646 | |
| ASLEEDAEPGPSSLG | 211 | Q03468 | |
| EAAAPTEVTEGPGVA | 186 | Q7L311 | |
| QDGPAAPADGSTVES | 651 | Q96KQ4 | |
| GEQPLSELESGEQPS | 126 | P26436 | |
| AQPSSPLEGQAEGVE | 1626 | Q2TAZ0 | |
| ALENGEPAGSAPETD | 1186 | Q8IZY2 | |
| GGPVAEQGIDPDAST | 836 | Q96QP1 | |
| EAPRPEEEGSGTALA | 1101 | Q9HCE9 | |
| PTVEPSSGEAEGGEA | 51 | Q9UBL3 | |
| EPSQAETAVEGDPSG | 116 | Q96B23 | |
| PNGSDESVPEAVGVI | 101 | Q8TDY8 | |
| ESVQGPAEEDTASPL | 276 | O95294 | |
| IVLESSPSQETPGDG | 446 | P29074 | |
| NESEQEPLLGDTPGS | 6 | Q8NHS3 | |
| LTATDPDQGPNGEVE | 266 | Q9NPG4 | |
| SSEEEQEPGFLPLSG | 1681 | Q96PE2 | |
| SGLQSPTGDDVDEQP | 2791 | Q01484 | |
| ASLEEDAEPGPSSLG | 211 | P0DP91 | |
| QVPSGEDEGPGAESA | 711 | Q9P2P5 | |
| EDEGPGAESATVPDQ | 716 | Q9P2P5 | |
| PQGGLETSQPESEAG | 86 | Q06416 | |
| GDSGPDSSDVVPAAE | 36 | Q5JQC4 | |
| ISIPGSETTDIEGEP | 4581 | Q8WXI7 | |
| PSQDDESGGIEDSPD | 666 | Q9H4G0 | |
| QEGEPSSIVNVPGES | 336 | O95819 | |
| ADADVPTSGVAPDGI | 981 | A5PL33 | |
| NPEEVKTPEEGEGQS | 101 | P0DTW1 | |
| EEPEETPGGQDESSN | 976 | Q92619 | |
| LDTAEEGPPSTAIQG | 561 | P78559 | |
| KGPAESPDEGITTTE | 886 | P46821 | |
| PSSDSEVGGAEVPER | 326 | Q8N653 | |
| DIETDPGISEPDGAT | 211 | Q9Y5V3 | |
| VPTEGNEGENPEDTK | 16 | Q9Y692 | |
| PNGPVEGTVIESFTD | 351 | P46199 | |
| GPVAVISGEEDSASP | 466 | Q16288 | |
| SLGDLPEGPEDQAVT | 161 | Q8TD08 | |
| QETEGRSSPGPDTLV | 246 | O60303 | |
| EDLSDVEGGGSEPTQ | 236 | O95671 | |
| SAGSEGFPETPVDDE | 1141 | Q2KJY2 | |
| PGHEDEEEPQSGSTA | 2796 | Q15751 | |
| EEEPQSGSTADSRPG | 2801 | Q15751 | |
| DKDTEQPGEVSALGP | 896 | Q12809 | |
| GADTTQQPLSLPEGE | 216 | Q8N448 | |
| PGEEVSEEGFQIPAT | 371 | O15075 | |
| EEEAPGQSPATLQGA | 51 | A0A1B0GUA6 | |
| EQEQSETEEGPPGSS | 1171 | Q9UKJ3 | |
| GTEAELPNSLPGDDQ | 591 | P98095 | |
| DLGSDNEEVVAGPAP | 281 | Q969U6 | |
| LDPGSVDTGSNDLPV | 476 | Q00613 | |
| PDEAGNLSPGSDVSD | 411 | Q7Z5P9 | |
| PSAEVTGLPGESAEV | 4236 | Q7Z5P9 | |
| GSDTEEGPSPQFTLD | 131 | Q9BRP1 | |
| VEAEPRSGSGPEAEA | 36 | Q8N8M0 | |
| SEQDGSVLSVPGPEG | 1131 | P39060 | |
| SDDGPTTEGIDLNDP | 101 | Q32MH5 | |
| TGGEQVDLSEPPDHE | 286 | Q6ZNL6 | |
| KPGDETTPQGDSADE | 1806 | O60229 | |
| QVGPADPAGDFEESS | 21 | Q9P1Y6 | |
| LVEDDVAPGGDQASP | 1066 | P48681 | |
| DEDGEASEDTPQVPG | 2301 | Q9UMN6 | |
| ADTGPPTDRGVQVTE | 421 | Q9BTN0 | |
| PIGNLPEDISTFGSD | 1656 | Q07864 | |
| REGPGTDQTEAEAPA | 131 | Q92985 | |
| PSESDSDLEPVGAGI | 196 | Q9BSJ6 | |
| EPGTEEERGADTAPT | 1011 | Q8IZL8 | |
| EGLPGPSDSSELVQE | 21 | P52790 | |
| QANPVGTPGSSEEDE | 481 | C9JSJ3 | |
| LPSSGGADEPSDLEE | 176 | Q9UKI9 | |
| SLAESDGETPPVEGL | 1306 | Q9Y2H9 | |
| PSGEVLETTAPGVED | 996 | P16112 | |
| PSGEVLETAAPGVED | 1091 | P16112 | |
| PSGEVLETAAPGVED | 1186 | P16112 | |
| PSGEVLETAAPGVED | 1281 | P16112 | |
| PSGEVLETAAPGVED | 1376 | P16112 | |
| GPRSESDLEDVGPTA | 516 | Q9H0B6 | |
| EEDVPGAVPLESIQG | 481 | O14522 | |
| EPGHQGEPEITETAA | 121 | P86480 | |
| TSLSESEGPRQPDGD | 376 | Q0D2I5 | |
| LQVPGGDSDEDSKTP | 5556 | Q5VST9 | |
| SQVGTEPGPSLDAEG | 7136 | Q5VST9 | |
| EPGHQGEPEITETAA | 121 | P86496 | |
| EPGHQGEPEITETAA | 121 | P86481 | |
| GARPDVTESESGSPE | 426 | P05187 | |
| AEGQEEVFTPPGDSQ | 21 | Q17RF5 | |
| ITFTGEADQAPGVEP | 231 | O60884 | |
| SEQSVGGPPELDTAS | 1586 | Q9Y2I7 | |
| SPSEQEEELPLGEGV | 386 | A2A2Y4 | |
| LPEPEQDNGGTTESV | 36 | Q9BS18 | |
| LTVSAENPDPQGGET | 776 | Q9BYE9 | |
| ESPAEGSKDEPGEQV | 606 | Q9Y4L1 | |
| DTGSPEPETRGVTAE | 1851 | Q9Y2F5 | |
| SEPEEPSGVEGAAFQ | 166 | O60341 | |
| PEAAQGDTEDSEGAP | 191 | Q8WUZ0 | |
| ATEEGARPPGSVEDA | 191 | Q5SW24 | |
| LEGPQQSGSLPEEGS | 411 | Q5SW24 | |
| SEGTEGSSLLPGEQP | 226 | P09603 | |
| EEASGEASEIPVPQG | 306 | P09603 | |
| AESNEEAPGEPSAGS | 101 | Q8N8A6 | |
| SATESTPGERGEEKP | 1641 | Q12873 | |
| SSNGFPDGEEDETPL | 356 | O43559 | |
| TPGFGNVEEIPENDS | 431 | Q495W5 | |
| GPPDSVVDVGSTEVT | 66 | Q6ICB0 | |
| EVSGVSDPQPQDAGS | 331 | O00257 | |
| ATPEAPGRGQDSLVD | 241 | A6NJJ6 | |
| TPGLSDTSPDEGLIE | 26 | Q9UL45 | |
| AITGPEDQPGSLEVN | 31 | Q12982 | |
| GTPEVGSTNTDERPD | 771 | Q12852 | |
| SSEEETAGTPAPEQG | 346 | Q9P2E8 | |
| AGPEEEPAGATESLQ | 126 | Q8TEP8 | |
| EAPPGETRTEAGAET | 271 | Q9GZR7 | |
| TPREEEGPAGEAAAS | 11 | Q9NR33 | |
| EVEKSSDGPGAAQEP | 26 | Q96DN0 | |
| SELGVPEQPDLQEGT | 326 | Q92538 | |
| GSQPQASSGPEAEEE | 2451 | Q8IWT3 | |
| DLTNFTDIPPGGVEE | 201 | O75521 | |
| IGTPDEGSNPEGIQS | 1021 | Q9NRM1 | |
| TEPQDILDGASPGGT | 246 | Q12951 | |
| DVTEDGESPEDPSGT | 306 | Q96G97 | |
| GESPEDPSGTEGQLS | 311 | Q96G97 | |
| DPSGTEGQLSEEEKP | 316 | Q96G97 | |
| GEAPGSPDTEQALSA | 261 | Q9NZ56 | |
| EDPAAEPAEAGVGTT | 181 | Q8IY37 | |
| EGSEVPESDRPAGAQ | 346 | Q6SPF0 | |
| NDGEESTDRTPLLPG | 11 | Q9NRA2 | |
| VLSQAPEDEGGSPEK | 941 | Q12770 | |
| APGEEDIQGPTKADT | 106 | P05060 | |
| DQDPVADREGSPVSG | 981 | Q5VVW2 | |
| EEIPNPAADEAGGTA | 956 | P42702 | |
| QAEPGIEAPSGTEAG | 31 | A6NK58 | |
| PISDRESEGGDVAPN | 101 | Q8N344 | |
| LDEPGVASDGLPSSE | 411 | Q8N344 | |
| GPEVSSGEGTENQPD | 26 | Q96DY7 | |
| SSDPGSVPDGEVLQN | 711 | Q96DY7 | |
| EVADEGPLEGSPSLA | 1031 | P09619 | |
| PGPEETSEKVENGSL | 281 | P60484 | |
| EPEELAENTSGGDHP | 251 | Q53GL7 | |
| AEGDQLSLPPQGTSD | 406 | Q8TB24 | |
| GPEDTPRESTEQGQD | 421 | Q8TB24 | |
| IEGSSAVGRQDPPET | 36 | Q16363 | |
| TLGAVGEAPTDPDSQ | 211 | O43427 | |
| SDLENTPGPDAGAQD | 401 | A1Z1Q3 | |
| EQPQEEDGITSDPGL | 426 | A1L443 | |
| TIGGLPESDDQSELP | 966 | Q8NEY1 | |
| VQPDVDGLESSPGDA | 101 | Q8NBV8 | |
| EDGEEPPGTSQTSPE | 141 | Q68CQ4 | |
| PVTATEASVPDGETD | 41 | Q96N64 | |
| SSFPDGEQIGPEDLS | 941 | O94972 | |
| APGTEEEGEALSSPQ | 541 | Q96PX1 | |
| AEDVLTVSPADGDPG | 36 | Q13424 | |
| GPPNGASKEISELEE | 2501 | Q8WUY3 | |
| ATENPEQVASEGLPE | 31 | Q9BYD3 | |
| DEQPGPSTSQEEGAA | 26 | P28370 | |
| PITNDGEDEFVPSDG | 1401 | Q02880 | |
| GENPVPAFQSDGTDE | 406 | Q9UPR3 | |
| SAPALQGSRPGETEE | 266 | Q9BVQ7 | |
| LLPTQGDSEEGLEEP | 61 | A2VDJ0 | |
| PDGLEPEATGESQQA | 216 | Q6IEE7 | |
| IEESGVGVFPSQDPA | 271 | Q9UMZ2 | |
| QEDGEESPSDGSPIE | 311 | Q7L5D6 | |
| AGEESTAGIPEAAPA | 91 | Q6T4R5 | |
| PSEEVEANSGGIEPE | 576 | Q8N4C6 | |
| GLSSPEQSPGTVEEN | 791 | O14827 | |
| SQVPAEEALSGAGEP | 76 | Q1AE95 | |
| GDPGATDTDGIPEET | 26 | Q15544 | |
| PDGDLGTDLDAINPS | 521 | O15353 | |
| GPGEAATSPAEETVV | 16 | Q9NV56 | |
| DEGSPVTQEPELASG | 946 | Q7Z3K3 | |
| PSEGVTAVPTSDLGE | 11 | O15218 | |
| LNGEAGPEDSTRETP | 186 | O15355 | |
| GPEDSTRETPSQENG | 191 | O15355 | |
| EPGHQGEPEITETAA | 121 | P86479 | |
| DLVGPPSNLEGQSDE | 1036 | Q9Y6Q9 | |
| EGTARPAETGDVQPD | 521 | Q8NDX1 | |
| QEQGVPISEVAESGP | 346 | P48065 | |
| SQSASGEERPPEADG | 361 | P48634 | |
| EPGHQGEPEITETAA | 121 | P86478 | |
| EGLPSPGSQAAEDLQ | 1476 | Q8TCU6 | |
| ECSTVDNPLPGEGEE | 1126 | Q15858 | |
| DPADGEGPETLSSAL | 1211 | Q9C0A6 | |
| GPGLEEEQDTQESLP | 451 | A0A0B4J2F2 | |
| GPGLEEEQDTQESLP | 451 | P57059 | |
| ITSEADSDPGNPVEL | 1026 | Q562F6 | |
| ATNLPPEDQDGSGDD | 26 | P18827 | |
| AETPAEIVDGGVPQA | 466 | Q9Y4R8 | |
| TQEISRPNSPSEGEG | 671 | Q9P2R6 | |
| TSGEVEVLDPNDPLG | 31 | Q01974 | |
| PPSLEDAGQQGSLSE | 421 | Q14160 | |
| VSEAEPEGPSAEAQG | 531 | Q14160 | |
| SPLGPEGSVEESEAE | 3161 | Q6ZRS2 | |
| GEESPPQSLASAAEG | 46 | O94819 | |
| PSVDPTNATGLDGRE | 196 | Q7RTU9 | |
| EATDSRTPEVPAGEG | 1991 | Q9H2D6 | |
| ISPPELGETEEGSIE | 561 | Q8TEV9 | |
| EGTEEAPIQATPGVD | 5546 | Q8IVF2 | |
| TPGVDSISGDLQPDT | 5556 | Q8IVF2 | |
| SISGDLQPDTGEPFE | 5561 | Q8IVF2 | |
| LTSPEAQDPGGEEEA | 231 | Q13286 | |
| SHLELSPGEPVQEGD | 301 | Q8IZ52 | |
| AGPGTSQAPEQVETE | 336 | Q96F05 | |
| QVETEATPGTDSTGP | 346 | Q96F05 | |
| PDGSESPTDQETTGV | 96 | P02452 | |
| ESKSEDPPGQEAGSE | 651 | O75153 | |
| DPPGQEAGSEEEGSS | 656 | O75153 | |
| RENGGTEPDASAPAE | 441 | Q86WB0 | |
| DGLSAPTEVGDSPLQ | 161 | Q63HN8 | |
| ELQAEATVSGSPEAP | 86 | Q9BZV1 | |
| SEEILGPDGNTPQFE | 166 | P17643 | |
| APQPQALSTAGEEEG | 416 | Q9BYN7 | |
| VNGAPDPTAGASIDD | 316 | Q9P217 | |
| ESAISDVTPENGPSG | 211 | O15062 | |
| IPPQEGEEVGESSEE | 1056 | Q9UDY2 | |
| PSQEETVAPGEAVQG | 481 | Q5TC79 | |
| DEEEGAPTTPQAEGA | 521 | O15156 | |
| TDPEGEGPAELALSS | 71 | Q9H171 | |
| LEVSGAEPQSAPDTG | 131 | Q8WVN6 | |
| SQVPAEEALSGAGEP | 76 | Q8IXX5 | |
| EDEGSQGTDAPTPGN | 141 | P0C1Z6 | |
| GSSAETAPEETEGPD | 971 | Q13009 | |
| EDEALGTPETGAATP | 1956 | Q15772 | |
| PEDGVDSASPSAQIG | 476 | Q8IWN7 | |
| TEGEAQPESEGIEAP | 2121 | Q8IWN7 | |
| PEAEGEAQPESEGET | 2231 | Q8IWN7 | |
| RDTEGGEEEPSKTQP | 521 | Q12767 | |
| DTDSTGSPDRDGIQP | 21 | Q9BQI5 | |
| TQEEEAGPGDVASPK | 296 | Q8N0S2 | |
| GPGANVASPLEDTEE | 1036 | O75038 | |
| VVDDEVSGPSAPGVD | 26 | A6NKU9 | |
| TEPTDGEQAGQPLLD | 21 | Q8N431 | |
| PGTEEQLSQDPGDET | 176 | Q6NSZ9 | |
| SQPEVETSPLGDGAS | 11 | Q9UM01 | |
| QEQGVPISEVAESGP | 341 | Q9NSD5 | |
| GSSQEDEDLDPPEGS | 146 | Q5MJ10 | |
| EEELVPTGSEPGDTR | 21 | Q9C0C2 | |
| PVAGDENEVTVPGLD | 1306 | P22105 | |
| DVNGDSEPDLVIGSP | 521 | P80108 | |
| SISQEEPQGEATPVG | 306 | Q9BUG6 | |
| DNEGLESPQDPSGES | 701 | O15015 | |
| STGETDPDDVSGVQP | 506 | Q8IZM8 | |
| VGSILSEGEESPSPE | 96 | Q9Y6I9 | |
| EGEGEEGLSVTPSSP | 576 | Q6ZSY5 | |
| GTRADEGSPVEPSQE | 666 | O15040 | |
| DQDGLELLTSGDPPT | 316 | Q04864 | |
| PQEEEGETAGEAPVS | 2091 | P11277 | |
| PIFGPEEVNSVEGNS | 21 | P01833 | |
| PEAGELPSIGEATAA | 631 | Q86UU1 | |
| EEPTDDSLPTTGDAG | 646 | Q9UKN8 | |
| EGVPPADSESKEVGS | 291 | Q9BUL5 | |
| SPGQTPEEGAQALAE | 16 | Q14166 | |
| AGALETELEGPSQPA | 456 | Q8IUG5 | |
| SELEEVPGLENGPTV | 181 | P0C7T8 | |
| EEEPGLGDSGIQSTP | 561 | Q9C0B5 | |
| GDALADPPSGTTEEE | 311 | Q8TBC5 | |
| PSEEAEPEAAGRGSQ | 136 | O14771 | |
| ENGDVPSQVEAGLPT | 126 | Q12901 | |
| PSVDPTNATGLDGRE | 196 | A6NGW2 | |
| SLELNGAVEPSEGAP | 206 | Q9NRL3 | |
| QEAGTPLPGQETAEE | 106 | P52746 | |
| QGEDPESPFTQSDEG | 531 | Q5QJ38 | |
| DQEGEGETPTPTESS | 811 | Q9UEG4 | |
| GGSEDQVEDPALSEP | 176 | Q9UD71 | |
| GEAPGALSTADPADQ | 41 | Q9UI38 | |
| SRGEIGDPQTENPST | 1866 | Q5T5U3 | |
| PDGVEGEPLVSSQSG | 366 | Q9H4Z2 | |
| EQAEGSEPTSGTEGP | 1276 | P08575 | |
| SISQEEPQGEATPVG | 306 | A6NGD5 | |
| TAPEPNESTEGDDGG | 601 | Q15911 | |
| ETVTEKEDGATPPDG | 241 | Q6PID6 | |
| GEEGPESSEFSLSPN | 56 | Q9UJN7 | |
| AQGGTVLPTEPQSEE | 116 | Q14789 | |
| DEDPSLVPEAIQGGT | 491 | O00629 | |
| VPLDPENGQTSGEEA | 16 | Q15418 | |
| GADSIPDPELSGESL | 411 | Q9C0E8 | |
| LPQPQAETGSGTESD | 16 | Q13765 | |
| AEDGGHLASEPEVQP | 1091 | Q13459 | |
| EDQSPTAEEPTGVFL | 41 | Q14324 |